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 Pseudomonas aeruginosa is a gram negative opportunistic pathogen which 
commonly infects hospitalized patients and those afflicted with cystic fibrosis. P. 
aeruginosa communicates intercellularly via a system of small diffusible molecules in 
the process of cell-to-cell signaling. The Pseudomonas quinolone signal (PQS) is one of 
these molecules and its synthesis is required for production of virulence factors such as 
pyocyanin. PQS is synthesized by the gene products of pqsABCD and pqsH, and it is a 
cofactor for the transcriptional regulator PqsR which then positively regulates the 
pqsABCDE operon. Many gene deletions have been identified that eliminate or 
suppress PQS production including biosynthetic and regulatory protein encoding genes. 
We have identified a gene which encodes an RpiR-type transcriptional regulator 
(PA5506; now designated qapR for quinolone alteration pathway regulator) that 
modulates PQS production through an unknown mechanism. A qapR deletion mutant 
was constructed in strain PAO1 and the phenotype of this mutant was characterized. 
The ∆qapR mutant produced less PQS and pyocyanin than the wild type strain PAO1. 
We found that transcription from the pqsA promoter is reduced in the ∆qapR mutant 
compared to wild type strain PAO1 and this reduction is due to decreased PQS 
concentration. Expression of PqsABCD in the ∆qapR mutant was able to complement 
PQS and pyocyanin production which indicates that PQS precursor pools are 
unaffected by qapR mutation. Using gel-shift assays we showed that qapR encodes a 
transcriptional regulator capable of binding to the qapR operon (containing genes qapR, 
PA5507, PA5508, and PA5509) promoter. Quantitative real-time PCR showed a large 
increase in transcription of genes PA5507, PA5508, and PA5509 when comparing the 
qapR mutant to the wild type. All three of these genes are required to reduce PQS 
concentration when transcriptional repression of the operon is alleviated. Further 
investigation of the qapR operon lead us to construct a point mutant that introduced a 
premature stop codon in the qapR open reading frame. This mutation led to 
derepression of the qapR operon but did not affect PQS concentration. We found 
expression of gene PA5507 restored the low PQS phenotype to the qapR-C90G point 
mutant. Reporter fusions translationally linked to PA5507 allowed us to show that 
translation of this gene is coupled to that of the upstream regulator qapR. This second 
level of regulation allows P. aeruginosa to have intricate control over the qapR operon 
which can reduce PQS concentration. 
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CHAPTER ONE: INTRODUCTION 
The impetus for conducting this research came from a study which identified 
genes required to produce 2-alkyl-4-hydroxyquinolones (HAQs) in Pseudomonas 
aeruginosa [14]. It has been shown that signaling via HAQs is important for infection of 
several model organisms including plants [87], nematodes [27], and mammals (mice) [9] 
and these molecules have been isolated from the lungs of cystic fibrosis patients 
colonized with P. aeruginosa [13]. In this study, an autolytic colony phenotype was 
produced by introducing a lesion into the pqsL gene. This phenotype reverted back to 
that of the wild type after a second mutation reduced quinolone production. This screen 
was utilized to identify genes required for quinolone biosynthesis, for quinolone 
precursor production, and for a transcriptional regulator encoded by gene PA5506 [105]. 
This gene is homologous to RpiR-type transcriptional regulators, but this did not indicate 
a clear role pertaining to quinolone production in P. aeruginosa [2].  
 
1.1 Pseudomonas 
Pseudomonads are members of the phylum Proteobacteria and class γ-
Proteobacteria which contains other bacteria of medical importance, including the 
Enterics and Vibrios. The genus Pseudomonas  was named in the 1890s by Walter 
Migula [78]. This genus now contains over 100 species which are mainly environmental 
organisms found in soil and water, and some of these act as pathogens of plants and 
animals [78]. The pseudomonads are able to grow on a wide range of nutrient sources 
that include various carbohydrates, fatty acids, amino acids, and long-chain 
hydrocarbons [95]. This metabolic diversity allows these organisms to reside in almost 
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every niche imaginable. In fact, Pseudomonas sp.  have been isolated from refrigerated 
meat [67], sewage [51], and even ash byproducts of coal-fired power plants [82]. Some 
Pseudomonads, such as P. putida, are also utilized for biotechnology applications [73] 
and in bio-remediation of contaminated soils [49]. 
 
1.1.1 P. aeruginosa.  
P. aeruginosa is the most well-known Pseudomonas species due to its 
prevalence as an opportunistic pathogen often encountered in the nosocomial 
environment [63]. This organism is a gram-negative bacterium that has long been 
acknowledged as a ubiquitous environmental organism, and is noted for its 
sophisticated ability to metabolize a vast array of compounds [95]. The genome of P. 
aeruginosa is comprised of approximately 6.3 million base pairs containing greater than 
5500 open reading frames (ORFs) [96]. These ORFs allow P. aeruginosa to exhibit 
wide nutritional diversity and complex regulatory patterns to adapt to changing niches 
[3]. Capable of growing anaerobically with a terminal electron acceptor such as nitrate 
or aerobically in the presence of atmospheric oxygen, P. aeruginosa is considered a 
facultative anaerobe [110]. These bacteria are motile via swimming with a polar 
flagellum or twitching with type 4 pilus [70]. P. aeruginosa is capable of sessile growth in 
the form of robust, multicellular communities called biofilms which form on surfaces of 
all types in nature and the nosocomial environment [103]. These biofilms form and 
differentiate into highly ordered structures, directed by the organisms within that sense 
and respond to various nutritional and environmental cues [44]. In a pathogenic setting, 
biofilms provide P. aeruginosa a means to resist physical processes such as 
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desiccation, provide a physical barrier to penetration by molecules (i.e., antibiotics) and 
immune cells (when in the context of an infection), and allow the organisms to exist in a 
low metabolic state which can also aid in antibiotic resistance [101]. 
 P. aeruginosa is known to be intrinsically resistant to many antimicrobials due to 
its hydrophobic lipopolysaccharide anchored to the outer membrane [60], 
chromosomally encoded enzymes such as ampC (which encodes a cephalosporinase) 
[61], and several efflux pumps [56]. Mutations in antibiotic targets can also lead to 
increased resistance as is the case for the quinolone class of antibiotics which target 
the DNA gyrase subunit A protein encoded by gyrA [108]. Antibiotic resistance can also 
be acquired laterally and lead to pan-resistance which has been noted for some clinical 
isolates [62].  
 
1.1.2 P. aeruginosa pathogenesis.  
Recently, P. aeruginosa has been recognized as a pathogen of many different 
organisms including plants, nematodes, animals, and as an opportunist in humans [9, 
21, 86, 87, 97]. P. aeruginosa was reported as the most frequently isolated organism 
from burn wounds by 46 of 104 U.S. burn centers [4].  Another study found that P. 
aeruginosa was the most commonly isolated causative agent of bacterial keratitis, 
causing approximately 40-70% of these infections [104].  The nosocomial environment 
is also rife with P. aeruginosa as evidenced by the large number of patients that it 
infects in the hospital setting [21]. Aside from immunocompromised and hospitalized 
patients, P. aeruginosa frequently colonizes and causes pathology in the lungs of those 
afflicted with cystic fibrosis (CF) [31]. Up to 25% of children with CF are colonized by 
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age 5 and 80% of adults with CF (age 25-34 years) are infected by P. aeruginosa, 
which causes significant morbidity and mortality [59]. This is especially troubling due to 
the increasing rate of antibiotic and multidrug resistant strains mentioned previously. 
One study conducted at the University of Colorado Hospital from 1998-2002 found 
multi-drug resistant isolates (resistant to imipenem, ceftazidime, ciprofloxacin and 
tobramycin) to have increased from 17% to 32% in the five year sampling period [41]. P. 
aeruginosa is known to be a prevalent causative agent of ventilator-acquired pneumonia 
(VAP) and significantly increases mortality in patients with VAP [33]. Since P. 
aeruginosa can be found in diverse environments, adaptability is a hallmark of this 
organism when free-living in nature, in a pathogenic setting, or in the transition between 
environmental and pathogenic lifestyle. This remarkable ability to adapt to 
environmental cues is borne from an intricate regulatory network and the utilization of 
small, diffusible chemicals produced for inter-cellular signaling. P. aeruginosa constantly 
keeps one ‘ear’ toward the environment and one toward other members of a local 
population by sensing and responding to these signals in the process of quorum 
sensing [26]. 
 
1.2 Cell-to-cell signaling.  
P. aeruginosa encodes three cell-to-cell signaling systems that are arranged in a 
hierarchy, but significant cross-talk exists between the systems [18, 52, 74]. Two 
systems have a function simliar to the well-studied N-acylhomoserine lactone (HSL) 
based LuxRI system of Vibrio fischeri [42]. These HSL signaling molecules are 
produced by a signal synthase, and as the concentration of these molecules increases 
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in the local environment it reaches a threshold where the signal can bind to its cognate 
receptor protein, which then alters gene expression at the transcriptional level [23]. 
 
1.2.1 las signaling system.  
One of the HSL-based signaling systems of P. aeruginosa is the LasRI quorum 
sensing system which is placed at the top of a signaling hierarchy (see Fig. 1.1) due to 
the positive influence this system exerts on the other HSL system (rhl)  and the 
quinolone signaling system [52, 92]. In the las system, the N-(3-oxododecanoyl) 
homoserine lactone (3-oxo-C12-HSL) signal (Fig. 1.2) is produced by the LasI enzyme, 
and as this signal concentration increases in the environment, LasR (the transcriptional 
regulator) binds 3-oxo-C12-HSL and the complex then binds DNA to regulate gene 
expression [29, 77]. Many genes are activated by LasR-3-oxo-C12-HSL such as lasB 
(encoding the virulence factor elastase) and lasI (encoding the 3-oxo-C12-HSL signal 
synthase), but many more genes are regulated indirectly via influence of the other cell-
to-cell signaling systems [29, 74]. In acute infections the las system is important for 
virulence [28], but in a chronic infection setting (such as the CF lung), LasR is 
dispensable for virulence and is often mutated [35]. 
 
 1.2.2 rhl signaling system.  
It has been shown that LasR-3-oxo-C12-HSL is required for activating 
transcription of the rhlR gene that encodes a transcriptional regulator which responds to 
the N-butyryl homoserine lactone (C4-HSL) signal (Fig. 1.2)  produced by the signal 
 
 Figure 1.1. Schematic of cell
signaling systems are interconnected and all three influence virulence factor production. 
Adapted from Wade et al. [99]
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synthase, RhlI [75, 80].  RhlR-C4-HSL can then activate transcription of numerous 
genes including rhlA, which encodes an enzyme required for synthesis of the 
biosurfactant rhamnolipid [71]. It must also be noted that a large portion (up to 6%) of 
the P. aeruginosa genome is influenced by the las and rhl signaling systems [92]. While 
the las system activates quinolone signaling, the rhl system antagonizes quinolone 
signaling to further fine tune virulence determinant expression [6, 65].                                                                                                 
 
1.2.3 Quinolone signaling system.  
The Pseudomonas quinolone signal (2-heptyl-3-hydroxy-4-quinolone) or PQS 
(Fig. 1.3) is one molecule of a series of 56 related HAQ compounds produced by P. 
aeruginosa [55]. This signaling molecule is important for virulence in multiple models of 
infection including the mouse lung and the nematode Caenorhabditis 
 elegans  [27, 53]. Furthermore, PQS has been detected in sputum from the lungs of CF 
patients infected with P. aeruginosa pointing to a role for PQS in human disease [13]. 
The LasRI system activates transcription of the genes pqsH and pqsR which are 
required for activation of the quinolone signaling system of P. aeruginosa [79, 99]. It has 
been shown that PQS can still be produced in a las signaling mutant, but production is 
delayed and the concentration is lower than wild type [20]. While the RhlR regulator can 
decrease PQS biosynthesis by binding to the pqs operon promoter [6], it is also required 
to activate virulence factors with the function of PqsE [25]. This illustrates that the cross-
talk between the signaling systems allows for genetic regulation in response to a very 
broad continuum of stimuli which help P. aeruginosa prevail as a pathogen (Fig. 1.1). To 
regulate quinolone synthesis, the transcriptional regulator PqsR binds PQS so that 
 Fig. 1.2. Chemical structures of N
produced by P. aeruginosa.
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 (A) N-3-oxo-C12-HSL. (B) C4-HSL. [79]. 
 
 
  
 
Fig. 1.3. Chemical structures of major alkylquinolones produced by 
aeruginosa.  [84]. 
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PqsR-PQS can then activate transcription of the pqsABCDE biosynthetic operon [14, 
27]. P. aeruginosa also integrates environmental signals into the regulation scheme for 
quinolone signaling by increasing PQS production in response to low phosphate or low 
iron growth conditions [40].  
The pqs operon is responsible for production of all quinolones including the 
antibiotic HQNO (Fig. 1.3) and HHQ (Fig. 1.3) which is the direct precursor to PQS [19, 
54]. The accessory gene pqsH encodes a monooxygenase that is required for the 
conversion of HHQ into PQS to allow full bioactivity of the quinolone signaling system 
[90]. It has been demonstrated that the precursors anthraniloyl-CoA, malonyl-CoA, and 
octanoyl-CoA are combined through the actions of PqsABCD to form HHQ [12, 22]. The 
study by Dulcey et al. [22] proved that quinolones are not produced from 3-keto-fatty 
acids as originally hypothesized [5]. Just as the other signaling systems have regulons 
of indirectly regulated genes, the PQS signaling system regulon is no different, being 
comprised of an estimated 237 genes [88]. PqsR-PQS has been shown to bind to the 
pqsA promoter, and it has been postulated that binding to the phnAB promoter also 
occurs [9], but this only accounts for 5-7 genes directly regulated by PqsR-PQS [9, 99]. 
The larger global regulatory role of PQS is attributed to the fifth gene of the pqs operon, 
pqsE, which encodes a protein of unknown function that is not required for PQS 
biosynthesis but is indispensable for responding to PQS and affecting transcription of 
PQS regulon genes [88]. However, it has also been shown that overexpression of pqsE 
can compensate for a loss of quinolone production by synergizing with the rhl system to 
affect production of many virulence factors including rhamnolipid and pyocyanin [25].  
Recently, it was shown that an alternate transcript originating in the coding region of 
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pqsC could drive expression of pqsDE-phnAB in a PQS-independent manner in 
response to tryptophan-deplete growth conditions [45], illustrating that P. aeruginosa 
has evolved several ways to produce PqsE even without PQS signaling. 
  Since quinolone biosynthesis provides another layer of regulation for fine-tuning 
P. aeruginosa virulence, it makes an attractive target for the development of anti-
infective compounds that could diminish virulence without necessarily being 
bactericidal. D’Argenio et al. identified many of the genes in P. aeruginosa that abolish 
or drastically reduce PQS concentration by use of an elegant screen that identified 
suppressor mutations in the autolytic pqsL mutant background [14]. The autolytic 
phenotype identified by D’Argenio et al. was shown to correlate with PQS 
overproduction but the direct mechanism contributing to autolysis is unknown [14]. Fig. 
1.4 shows the genes identified by the suppressor mutagenesis screen of D’Argenio et 
al. This study identified not only the biosynthetic operon for quinolone production but 
also accessory genes for PQS and HQNO production such as pqsH and pqsL 
(respectively), and genes that provide required precursors such as kynurenine [24]. One 
gene (PA5506) shown to modulate PQS concentration in the D’Argenio study encodes 
a homolog of an RpiR-type transcriptional regulator. Organic extracts from a PA5506 
mutant are shown in   Fig. 1.5 visualized by thin layer chromatography. This figure 
shows increased PQS produced by the pqsL mutant compared to the wild type strain 
and the reduced PQS in the PA5506, pqsL double mutant. Gene PA5506 affected the 
concentration of the PQS signal in P. aeruginosa through an unknown mechanism, and 
its role in PQS production is the basis for this dissertation. 
 
  
Figure 1.4. Genes identified in autolysis reversion screen in 
white arrowheads denote insertions which yielded the autolytic phenotype. Filled 
arrowheads denote insertions in genes which reverted autolytic colonies to wild type 
morphology. Stars indicate insertions that were further characterized by D’Argenio 
[14]. 
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1.3 RpiR-type regulators. 
This family of transcription factors is so named for the prototype from Escherichia 
coli that represses expression of rpiB, which encodes ribose-phosphate isomerase B (a  
part of the oxidative pentose phosphate pathway) [94]. Most members of this family 
regulate genes of central metabolism in response to a pathway intermediate or 
precursor. These transcription factors contain an N-terminal helix-turn-helix (HTH) DNA 
binding domain and C-terminal sugar isomerase [SIS] domain shown to bind a cofactor  
[15, 94]. GlvR, an RpiR homolog from Bacillus subtilis, has been shown to activate 
transcription of genes required for maltose metabolism in response to maltose-6-
phosphate [107]. However, most characterized RpiR homologs function as repressors 
of carbohydrate catabolic enzymes. This is the case for ribose and N-acetylmuramic 
acid catabolism in E. coli and hexose catabolism in P. putida which are all repressed by 
RpiR homologs [15, 39, 94].  In the case of P. putida, the RpiR homolog HexR is named 
for its role in the repression of genes of the glucose phosphorylative pathway and 
Entner-Doudoroff (ED) pathway [15]. It was also shown that a metabolic intermediate of 
the ED pathway, 2-keto-3-deoxy-6-phosphogluconate, served as the co-factor for HexR, 
which upon binding allowed the protein to dissociate from DNA in vitro and derepress 
transcription of target genes [15]. RpiR homologs can regulate not only enzymes of the 
pentose phosphate pathway but also virulence factor expression through RNAIII 
transcription in the opportunistic pathogen Staphylococcus aureus [109]. Interestingly, in 
S. aureus, RNAIII transcription is linked to the agr small peptide signaling system [69]. 
While small peptide signaling is not homologous to cell-to-cell signaling in P. 
aeruginosa, it is thought-provoking that another opportunistic pathogen would 
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Fig. 1.5. Thin layer chromatography of PQS extracts. Wild type strain PAO1 (WT), 
pqsL (pqsL64 transposon mutant), PA5506, pqsL (PA5506 transposon mutant in ∆pqsL 
background) [14]. 
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encode transcription factors that allow concerted regulation of virulence via intercellular 
signaling in response to metabolic cues. 
 The RpiR-type regulator investigated here was found to repress transcription of 
an operon that contains itself and three downstream genes (PA5507, PA5508, and 
PA5509). PA5507 encodes a protein with sequence homology to isochorismatases, 
PA5508 encodes a protein with sequence homology to glutamine synthetases and has 
been shown to exhibit γ-glutamyl aromatic monoamine ligase activity in vitro [50], and 
PA5509 encodes a protein with sequence homology to amidohydrolases [2]. The 
putative functions of these enzymes does not suggest a reaction directly involving 
HAQs, but we have found that overexpression PA5507, PA5508, and PA5509 has a 
negative effect on PQS concentration.  
 
1.4 Translational coupling.  
 Bacterial genes are sometimes co-regulated by a single promoter when genes 
are arranged into operons that are transcribed as polycistronic mRNAs. Translation of 
each ORF in a polycistronic mRNA is most commonly initiated at a ribosome binding 
site (RBS) upstream from the ORF. Each ORF typically has an RBS dedicated to 
initiating translation of a single protein but some ORFs have been found with no 
identifiable RBS. ORFs that overlap one another or that lack a functional RBS can 
potentially be regulated through post-transcriptional mechanisms. Translational coupling 
is a post-transcriptional regulatory mechanism which allows for control of protein 
stoichiometry produced from operons in bacteria and bacteriophage [38, 72]. In most 
cases of translational coupling, translation of a downstream ORF is positively affected 
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by translation of an ORF directly upstream. Translation of the upstream ORF can affect 
the downstream ORF by either alleviating mRNA secondary structure to allow internal 
ribosomal initiation of the downstream ORF [7], or by re-initiation of ribosomes that have 
translated the upstream ORF and terminated near the translational start codon of the 
downstream ORF [48]. Maintenance of protein stoichiometry through translational 
coupling is important for structures composed of multiple protein subunits such as the 
DNA injection apparatus from Agrobacterium tumefaciens [68]. Careful control of the 
translation of regulatory proteins such as those composing two component systems that 
sense environmental cues can be post-transcriptionally regulated by translational 
coupling [58]. Commonly, translationally coupled ORFs are overlapping one another or 
have their respective stop and start codons in close proximity. However, genes can be 
transcribed in operons with overlapping ORFs that are not regulated by translational 
coupling [43]. In Chapter 3 of this dissertation, we present data which show that 
translational coupling of an ORF to the PA5506 transcriptional regulator plays a role in 
the modulation of PQS concentration. This regulatory mechanism may have evolved to 
allow for tight control of expression of PA5507 which acts with PA5508 and PA5509 to 
reduce PQS concentration through an unknown mechanism [98].   
  
 
CHAPTER TWO: QAPR (PA5506) REPRESSES AN OPERON THAT 
NEGATIVELY AFFECTS THE PSEUDOMONAS QUINOLONE SIGNAL IN 
PSEUDOMONAS AERUGINOSA 
2.1 Summary 
Pseudomonas aeruginosa is a gram negative, opportunistic pathogen that can 
cause disease in varied sites within the human body and is a significant source of 
morbidity and mortality in those afflicted with cystic fibrosis. P. aeruginosa is able to 
coordinate group behaviors, such as virulence factor production, through the process of 
cell-to-cell signaling. There are three intercellular signaling systems employed by P. 
aeruginosa and one of these systems utilizes the small molecule 2-heptyl-3-hydroxy-4-
quinolone (Pseudomonas quinolone signal; PQS). PQS is required for virulence in 
multiple infection models and has been found in the lungs of cystic fibrosis patients 
colonized by P. aeruginosa. In this report, we have identified an RpiR-family 
transcriptional regulator, QapR, which is an autoregulatory repressor. We found that 
mutation of qapR caused overexpression of the qapR operon. We characterized the 
qapR operon to show that it contains genes qapR, PA5507, PA5508, and PA5509, and 
that QapR directly controls the transcription of these genes in a negative manner. We 
also show that derepression of this operon greatly reduces PQS concentration in P. 
aeruginosa. Our results suggest that qapR affects PQS concentration by repressing an 
enzymatic pathway that acts on PQS or a PQS precursor to lower PQS concentration. 
We believe that this operon comprises a novel mechanism to regulate PQS 
concentration in P. aeruginosa. 
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2.2 Introduction 
Pseudomonas aeruginosa is a ubiquitous, gram negative bacterium that can 
infect a broad range of hosts including insects, plants, and animals [16, 87, 97]. This 
prevalent opportunistic pathogen is frequently acquired in the nosocomial setting and 
causes intractable infections in the lungs of cystic fibrosis patients [13, 21, 31]. The 
ability of this organism to colonize and cause disease is tied to its vast array of virulence 
factors such as pyocyanin, alkaline protease, hydrogen cyanide, elastase, and 
rhamnolipid which are produced in response to intercellular signals [18, 74, 92, 100]. 
 There are three cell-to-cell signaling systems that P. aeruginosa utilizes to 
coordinate expression of numerous genes for metabolic processes and virulence factor 
production [92, 100]. The lasRI signaling system is at the top of the cell-to-cell signaling 
hierarchy and positively regulates the rhlRI and quinolone signaling systems [80]. The 
las and rhl systems produce and respond to the acyl-homoserine lactone signals, N-(3-
oxododecanoyl)-L-homoserine lactone (3-oxo-C12-HSL) and N-butyryl-L-homoserine 
lactone (C4-HSL), respectively [75, 77]. The other cell-to-cell signaling system functions 
through the quinolone compound 2-heptyl-3-hydroxy-4-quinolone (the Pseudomonas 
quinolone signal (PQS)) [79]. Production of PQS is mediated by the products of the 
pqsABCD operon and the pqsH gene, and occurs through the condensation of the 
precursors anthranilate and β-ketodecanoic acid [5]. PQS then interacts with and 
activates PqsR, which positively controls expression of the PQS biosynthetic operon 
(pqsABCDE) in an autoregulatory loop [99]. Transcription of the pqsR gene is regulated 
in a complex manner by the las and rhl signaling systems [30, 99]. The quinolone 
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biosynthetic machinery also produces 55 other 4-quinolone compounds, many of which 
function as antimicrobials [55].  
 A prior study of factors that control the autolytic phenotype of P. aeruginosa 
identified 10 mutated genes that altered PQS production [14]. Subsequent 
investigations of these genes have yielded a wealth of knowledge about the precursors 
and biosynthesis of PQS in P. aeruginosa [12, 24, 46, 90]. One of the mutants was 
found to have a disruption in gene PA5506 [hereafter referred to as qapR for quinolone 
alteration pathway regulator] which encodes an RpiR-family transcriptional regulator 
homolog. RpiR homologs are usually transcriptional repressors of carbohydrate 
metabolic genes [15, 94]. In this report, we present data demonstrating that QapR is a 
negative autoregulatory transcription factor that controls a four gene operon. We show 
that the qapR-PA5509 operon has a negative effect on PQS concentration to provide 
another layer of regulation for quinolone signaling. 
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2.3 Materials and Methods 
2.3.1 Bacterial strains, plasmids, and growth conditions.  
Bacterial strains used in this study are listed in Table 1. Strains of P. aeruginosa 
and Escherichia coli were maintained at -70oC in 10% skim milk (Becton-Dickinson) or 
15% glycerol, respectively. Bacteria were freshly plated from frozen stocks to begin 
each experiment and bacteria were grown in Luria-Bertani [LB] medium as noted below 
[89]. When required to maintain plasmids, cultures were supplemented with 200 µg/ml 
carbenicillin for P. aeruginosa and 100 µg/ml ampicillin for E. coli. Arabinose (Sigma-
Aldrich) was added to cultures to induce expression of genes under the control of the 
PBAD promoter where indicated. 
 Plasmids used in this study are listed in Table 2.1. To generate an expression 
plasmid for qapR, a 1078 bp DNA fragment, which began at the qapR start codon 
(ATG) and ended 220 bp downstream from the stop codon, was amplified by PCR using 
chromosomal DNA from strain PAO1 as a template. The oligonucleotide primers used 
for PCR were engineered to include an XbaI site upstream from the start codon and a 
HindIII site downstream from the stop codon. The fragment was purified from an 
agarose gel with a gel extraction kit (MPBio). Vector plasmid pHERD20T [85], which 
contains a PBAD promoter to control gene expression, was digested with XbaI and HindIII 
restriction enzymes (New England Biolabs). PCR-amplified DNA fragments were also 
digested with XbaI and HindII and prepared fragments were ligated to produce the PBAD-
qapR expression plasmid pqapROE.  
To generate a PA5507-5509 expression plasmid, a 2,818 bp DNA fragment that 
began at the PA5507 start codon (ATG) and ended 100 bp downstream from the 
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PA5509 stop codon was amplified using PAO1 genomic DNA as a template. Primers 
were engineered to include an NcoI restriction site upstream from the PA5507 start 
codon and a HindIII site downstream from the PA5509 stop codon. Vector pHERD20T 
and PA5507-5509 DNA were both digested with NcoI and HindIII and the resulting 
fragments were gel purified. Fragments were then ligated to produce the PBAD-PA5507-
5509 expression plasmid p5507-09OE.   
A PQS biosynthetic operon expression plasmid was generated by amplifying a 
4,577 bp fragment that began at the pqsA start codon (ATG) and ended 83 bp 
downstream from the pqsD stop codon. Primers were engineered to include an NcoI 
restriction site upstream from pqsA and an XbaI restriction site downstream from pqsD. 
Vector pHERD20T and the pqsABCD-containing fragment were digested with NcoI and 
XbaI and both fragments were gel purified. Fragments were then ligated to produce the 
PBAD-pqsABCD expression plasmid pPQSsynOE. 
 In order to generate a qapR’-lacZ reporter plasmid, a 300 bp DNA fragment 
corresponding to bp -230 to +70 relative to the qapR translational start site was 
amplified via PCR with strain PAO1 genomic DNA as a template. PCR primers were 
engineered to include a HindIII site and an XbaI site upstream and downstream from the 
fragment, respectively. The DNA fragment and pLP170 were digested with HindIII and 
XbaI and were ligated together. The resulting plasmid, pLP5506, harbors the qapR 
promoter transcriptionally fused to the lacZ gene.  
 To generate the pqsR’-lacZ chromosomal reporter fusion, an 850 bp DNA 
fragment corresponding to bp -776 to +94 relative to the pqsR translational start site 
was amplified via PCR with strain PAO1 genomic DNA as a template. PCR primers 
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were engineered to include a PstI site and a HindIII site upstream and downstream from 
the fragment, respectively. The DNA fragment and pUC18-mini-Tn7T-Gm-lacZ were 
digested with PstI and HindIII and were ligated together. The resulting plasmid, pJF-
Tn7T-pqsR’Tc, harbors the pqsR promoter transcriptional fusion that can be integrated 
into strains as a chromosomal fusion as in Choi & Schweizer [11].  
 All plasmids were confirmed by DNA sequencing of insert DNA. All primers for 
these studies are listed in Table 2.2. 
 
2.3.2 Generation of mutant strains.  
Mutant P. aeruginosa strains were generated as described previously [34]. 
Mutant alleles were generated using a splicing by overlap extension (SOE) PCR 
protocol [37]. The mutant alleles contain in-frame deletions in the coding DNA sequence 
corresponding to amino acids 30 to 275 for qapR (86% of protein sequence), 19 to 204 
for PA5507 (84% of protein), 28 to 421 for PA5508 (89% of protein), and 32 to 198 for 
PA5509 (75% of protein). Oligonucleotide primers used to generate mutant alleles also 
contained the following restriction sites at each end: BamHI for qapR and PA5509, XbaI 
for PA5507 and PA5508. The fragments were digested with the appropriate enzyme 
and ligated into pEX18Ap that had been previously digested. This ligation produced the 
suicide vectors p∆qapR, p∆5507, p∆5508, p∆5509. To transfer the mutant alleles onto 
the P. aeruginosa PAO1 chromosome, each plasmid was electroporated into cells and 
integrants were selected as described by Choi & Schweizer [11]. Potential mutants were 
screened by PCR using appropriate primers and mutants were further confirmed by 
sequencing of generated PCR products.  
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2.3.3 Assays for PQS and pyocyanin.  
To assay for PQS production, bacteria from frozen skim milk stocks were plated 
on LB medium with antibiotics as necessary. Isolated colonies were used to inoculate 
10 ml LB broth cultures which were incubated at 37oC with vigorous shaking for 18 h. 
PQS was extracted as described by Calfee et al. [8] and PQS extracts were visualized 
as described by D’Argenio et al. [14]. Images were then analyzed using Quantity One 
software (Invitrogen) to quantify PQS by densitometry. 
 For pyocyanin extraction, cultures were grown from freshly plated bacteria as 
above. Isolated colonies were used to inoculate 10 ml LB broth cultures which were 
incubated at 37oC for 18 h with vigorous shaking. Samples of cultures were centrifuged 
at 16,000 x g to remove cells and 500 µl of supernatant was transferred to a clean tube. 
The supernatant was then extracted and analyzed for pyocyanin production as 
previously described by Farrow et al. [24]. 
 
2.3.4 β-Gal assays in P. aeruginosa.  
Cells from overnight cultures were washed in LB medium and used to inoculate 
10 ml LB cultures to an OD660 of 0.05. Cultures were incubated at 37oC with vigorous 
shaking. At 6 and 24 h, aliquots were collected and β-Gal activity was assayed in 
duplicate. Activity is reported in Miller units as the mean ± standard deviation of at least 
three separate replicates . 
 For experiments including the addition of PQS, cells from overnight culture were 
washed in LB medium and used to inoculate 2 ml LB cultures with or without the 
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addition of 30 µM PQS in acidified ethyl acetate. PQS or ethyl acetate (as a control) was 
evaporated under N2 gas in 13 ml capped tubes prior to the addition of culture. Cultures 
were then incubated at 37oC with vigorous shaking. β-Gal activity was assayed at 24 h 
in duplicate as above. Activity is reported in Miller units as the mean ± standard 
deviation of at least three independent experiments [66]. 
 
2.3.5 RNA isolation.  
Overnight cultures of strains PAO1 and PKT-QapR1 were washed in LB medium 
and used to inoculate 10 ml LB broth cultures to an OD660 0.05. Cultures were incubated 
at 37oC for 3 h or to an OD660 of approximately 1.5 prior to centrifugation at 4oC to 
harvest bacterial cells. Total cellular RNA was isolated from P. aeruginosa cultures 
using the RNeasy Midiprep kit following the manufacturer’s protocol (Qiagen). 
Contaminating DNA was removed by treatment of RNA samples with RQ1 DNase 
following the manufacturer’s protocol (Promega). RNA was then extracted with 1:1 
phenol:chloroform and collected by ethanol precipitation. Purified RNA was 
resuspended in nuclease-free water. RNA concentration was quantified with a 
Nanodrop ND-1000 spectrophotometer. 
 
2.3.6 Transcript analysis by reverse transcriptase PCR (RT-PCR).  
Purified RNA (50 ng) from strain PAO1 was used as a template for RT-PCR 
performed with the Promega Access RT-PCR system following the manufacturer’s 
protocol. Primer pairs were designed to span intergenic regions of all genes of interest. 
All cDNA synthesis and PCR amplification steps were performed in an Eppendorf 
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Mastercycler with the following parameters: cDNA synthesis at 45oC for 45 min; 95oC 
for 2 min; 30 cycles of 95oC for 30 sec, 55-62oC for 30 sec (different annealing 
temperatures were required to optimize different primer sets), 72oC for 45 sec. The final 
cycle was followed by heating the samples at 72oC for 5 min. Positive controls were 
performed using genomic DNA and negative controls were performed without the 
addition of reverse transcriptase enzyme. Reaction products were analyzed by agarose 
gel electrophoresis.  
 
2.3.7 cDNA synthesis for quantitative real time-PCR.  
Total RNA was isolated from strains PAO1 and PKT-QapR1 and purified as 
described above. cDNA was synthesized in a 21 µl reaction volume from 5 µg of total 
RNA using a 1:1 mixture of GC-rich hexamers (Gene Link) and random hexamers 
(Invitrogen) for priming with 40 µM dNTPs (USB). Reactions were then heated at 65oC 
for 5 minutes followed by cooling to 4oC for 1 minute. Following this step 200 units of 
SuperScript III reverse transcriptase in First Strand buffer (Invitrogen) with dithiothreitol 
and RNase Out RNase Inhibitor (Invitrogen) were added to each reaction yielding a final 
volume of 30 µl. Reactions were then heated to 25oC for 5 minutes, followed by 50oC for 
60 minutes, then 75oC for 15 minutes.  
 
2.3.8 Quantitative Real Time-PCR.  
cDNA and total RNA to be used as template and negative control, respectively, 
were diluted 1:200 in nuclease-free water. Oligonucleotide primer pairs for qRT-PCR 
were generated by the Primer-Blast program available at 
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www.ncbi.nlm.nih.gov/tools/primer-blast/. Primers were designed to amplify a 200 bp 
fragment of rplU (control), a 213 bp fragment of PA5507, a 140 bp fragment of PA5508, 
and a 199 bp fragment of PA5509 as target genes. qRT-PCR was performed using 
FastStart SYBR Green Master mix (Roche Diagnostics) with the BioRad CFX96. The 
following cycle was utilized to amplify and quantify fragments: 95oC for 10 minutes; 
95oC for 15 seconds, 55oC for 15 seconds, and 72oC for 20 seconds - repeated 40 
times. Melt curve data was collected to ensure amplification of one fragment by heating 
samples from 65oC to 95oC in 0.5oC increments. Data were generated from three 
separate RNA/cDNA preparations and at least two technical replicates for each primer 
set. Relative expression of each gene was determined by comparing target genes with 
the control gene (rplU) using the Pfaffl method [81]. 
 
2.3.9 Preparation of E. coli lysate containing QapR.  
Overnight cultures of E. coli strain DH5α harboring the empty vector pHERD20T 
or the expression vector pqapROE were subcultured to an OD600 of 0.08. Cultures were 
incubated at 37oC with vigorous shaking for 2.5 h and then l-arabinose was added to a 
final concentration of 1% to induce expression of QapR. The cultures were allowed to 
grow for another 2.5 h following addition of arabinose. After 5 h of total growth, cells 
were harvested from cultures by centrifugation at 6,000 x g for 10 min at 4oC. Bacterial 
cell pellets were resuspended in 1 ml of STE buffer (10 mM Tris-HCl, 1 mM EDTA, 100 
mM NaCl) and this suspension was passed through a French pressure cell at 16,000 
psi to yield whole cell lysate. Protein concentration for DNA mobility shift assay was 
assessed using a Bradford assay (Bio-Rad). 
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2.3.10 DNA mobility shift assay.  
PCR was used to generate DNA fragments containing the qapR (198 bp) or pqsA 
(300 bp) promoter region. DNA probes were labeled with 32P using [γ-32P]ATP (Perkin-
Elmer) and T4 polynucleotide kinase (Invitrogen). Binding reactions were carried out in 
buffer containing 50 mM Tris-HCl, pH 7.5, 10 mM NaCl, 0.1 mM EDTA, 1 mM 
dithiothreitol, and 5% glycerol [15]. Each reaction contained 0.3 µg salmon sperm DNA, 
106 cpm of radiolabeled probe and 0 to 1 µg of lysate protein. Reaction mixtures were 
incubated at room temperature for 20 min and separated by electrophoresis on a native 
6% polyacrylamide gel in 0.5X tris-borate-EDTA buffer at 4oC. Gels were then exposed 
to X-ray film to visualize radiolabeled bands. 
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2.4 Results 
2.4.1 qapR controls PQS concentration.  
Previously, it was shown that disruption of qapR (gene PA5506) caused 
decreased PQS production and suppression of autolysis in a pqsL mutant that 
overproduced PQS [14]. In order to investigate this phenotype, we constructed an 
isogenic qapR mutant and analyzed PQS levels. This mutant exhibited a reduction in 
PQS concentration in 18 h cultures compared to strain PAO1 (Fig. 2.1A). PQS 
concentration could be restored to wild type levels in the qapR mutant when qapR was 
provided on a plasmid (Fig. 2.1A). In addition, mutation of qapR caused a decrease in 
pyocyanin production in a manner similar to the effect seen for PQS (Fig. 2.1B). This 
was expected since pyocyanin biosynthesis is positively controlled by PQS. Taken 
together, the data of Fig. 2.1 confirm that PQS concentration is controlled by qapR. 
 
2.4.2 Transcription of the PQS biosynthetic operon, but not pqsR, is altered in the 
qapR mutant.  
In order to dissect the mechanism by which qapR modulates PQS concentration, 
we first assessed its effects on the transcription of the PQS biosynthetic operon. We 
found that pqsA transcription decreased in the qapR mutant as compared to the wild 
type strain PAO1 (Fig. 2.2A). Since the pqsA promoter is activated by PqsR-PQS [99], 
deficiency of either PqsR or PQS can cause reduced activation of the biosynthetic 
operon. To test whether PqsR was active in the qapR mutant, we added synthetic PQS 
to cultures and assessed pqsA activation. As can be seen in Fig. 2.2A, the addition of 
PQS to cultures restored pqsA’-lacZ transcription in the qapR mutant strain to the level 
  
  
Figure 2.1. Mutation of qapR decreased PQS concentration in 
Strains are indicated below each bar and the presence of 
(pqapROE) or control vector (pHERD20T) is indicated with a plus (+) or minus (
respectively. PAO1 is the wild type strain and 
were grown for 18 h in LB medium supplemented with 1% 
extracted and quantified as described in Materials and Methods. Data are presented as 
the averages +/- standard deviation (SD) of three independent experiments. (B.) 
Pyocyanin was extracted and quantified from cultures grown for 18 h in LB medi
supplemented with 1% L-arabinose. Data are presented as averages +/
independent experiments.  
29 
 
P. aeruginosa
qapR expression plasmid 
∆qapR is strain PKT-QapR1. (A.) Cultures 
L-arabinose and PQS was 
- SD of three 
 
 
. 
-), 
um 
 30 
 
produced by strain PAO1. This suggested that PqsR expression is unaffected in the 
qapR mutant and we confirmed this by assessing transcriptional activity from the pqsR 
promoter (Fig. 2.2B). These data implied that PQS concentration is the cause of the 
decreased pqsA transcription in the qapR mutant. To confirm this, we expressed the 
PQS biosynthetic operon (pqsABCD) from an inducible promoter in the qapR mutant 
strain and assayed for PQS and pyocyanin. We found that expression of the PQS 
biosynthetic operon restored PQS concentration and pyocyanin production in the qapR 
mutant background (Fig. 2.2C and 2.2D). These results showed that the qapR mediated 
modulation of PQS concentration can be overcome by PQS-independent expression of 
the pqsABCD operon. This implies that the precursors for PQS production are present 
and that expression of the quinolone synthetic machinery is affected by qapR mutation. 
Since anthranilate is critical for the production of PQS [24], we supplemented cultures 
with anthranilate to determine that this precursor was not depleted in the qapR mutant. 
We found that supplementation of culture media with anthranilic acid could not 
restore PQS concentration in the qapR mutant strain (data not shown). Results of these 
experiments implied that expression of the pqsABCD operon is affected only by  
decreased PQS level due to mutation of qapR. This spurred us to look more closely at 
qapR and the genes adjacent to it. 
 
2.4.3 Characterization of the qapR-PA5509 operon.  
In order to understand the role of qapR, it was necessary to analyze the putative 
operon that it leads. The qapR gene is predicted to be at the 5’ end of a four gene  
 Figure 2.2. Supplementation of PQS can restore transcription of the PQS operon 
in the qapR mutant. (A.) Strains carrying a 
for 24 h with 30 µM PQS where indicated by a plus symbol (+). 
assayed and is presented in Miller units as the mean +/
assays from three separate experiments. Stra
the wild type strain and ∆qapR
fusion integrated into the chromosome were grown for 24 h in LB medium. 
produced in each culture was then assayed an
+/- SD of results from duplicate assays from three separate experiments. (C.) Strains 
carrying the PQS biosynthetic operon (pPQSsyn) or control vector (pHERD20T) 
indicated by a plus (+) or minus (
supplemented with 1% L-arabinose. PQS was extracted and quantified as described in 
Materials and Methods. Data are presented as the averages +/
independent experiments. (D.) Pyocyanin was extracted and quantif
grown as described in (C.). Data are presented as averages +/
independent experiments. 
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polycistronic operon which includes the three downstream genes, PA5507-5508-5509 
[64].These genes are illustrated in Fig. 2.3A, along with the gene PA5510. It has been 
reported that gene PA5508 encodes an enzyme that exhibits γ-glutamyl aromatic 
monoamine ligase activity while a BLAST search shows that genes PA5507 and 
PA5509 are predicted to encode proteins with sequence homology to iso-chorismatases 
and amidohydrolases, respectively [50]. To analyze the operon structure, we utilized 
reverse transcriptase PCR from total RNA extracted from strain PAO1. We found that 
qapR is co-transcribed with genes PA5507, PA5508, and PA5509 (Fig. 2.3B). A link 
between genes PA5509 and PA5510 was not indicated by our data (Fig. 2.3B). Since 
qapR is co-transcribed with three downstream genes, and other RpiR homologs have 
been shown to be autoregulatory, we examined the role of QapR in the control of this 
four gene operon. 
To investigate regulation of the qapR operon, a qapR’-lacZ reporter fusion was 
constructed and we assessed transcriptional activity from the qapR promoter in strain  
PAO1 and in the qapR mutant strain. Fig. 2.4A shows that transcription from the qapR 
promoter is significantly higher in the qapR mutant compared to strain PAO1. This was 
not surprising since most RpiR homologs have been demonstrated to act as repressors 
of transcription [15, 39, 47, 94]. To further analyze the regulation of the qapR operon, 
we performed quantitative real time-PCR (qRT-PCR) to assess the relative expression 
of genes PA5507, PA5508 and PA5509 in the qapR mutant strain. The results of these 
experiments showed that each target gene is expressed at a level 15 to 20 fold higher in 
the qapR mutant strain when compared to the wild type strain PAO1. These data  
 
  
  Figure 2.3. qapR is the first gene of a four gene operon.
the predicted qapR operon and gene 
relative position of primers used to amplify each intergenic region. (B.) Agarose gel 
visualization of products from RT
primers specific for each intergenic region of 
‘RT’ for reverse transcriptase, ‘+’ for positive control and ‘
Chromosomal DNA was used as a template for positive controls, and for negative 
controls, reverse transcriptase was omitted from re
Kb Plus Ladder, Invitrogen) are labeled ‘L’ and relevant masses (noted as bp) are 
indicated next to the image. 
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 (A.) Schematic diagram of 
PA5510. Arrows below the schematic indicate the 
-PCR experiments performed with oligonucleotide 
the qapR operon. Reactions are labeled 
-’ for negative control. 
actions. Molecular mass ladders (1 
 
 34 
 
confirm that the qapR operon is derepressed in the qapR mutant and suggested that 
QapR is the repressor.  
To test if QapR directly regulates the qapR operon, we assessed direct binding of 
the protein to the promoter by electrophoretic mobility shift assay (EMSA). To 
investigate this, E. coli cell lysates containing QapR were utilized in EMSA experiments 
with the qapR operon. The data showed that lysates containing QapR interacted with 
the radiolabeled qapR operon promoter region causing a shift in DNA mobility          
(Fig. 2.5A). A minimal amount of protein (0.1 µg of cell lysate) was able to alter the 
mobility of the  
qapR promoter probe and this effect intensified as increasing protein was added 
(up to 1 µg). The mobility of the qapR fragment was unaffected by a control lysate 
prepared using E. coli that harbored the parent expression vector (Fig. 2.5A), indicating 
that the observed binding is due to the presence of QapR. We also assessed lysate 
binding to the pqsA promoter and observed no interaction (Fig. 2.5B). This result 
provided further evidence against the possibility that QapR is directly affecting pqsA  
transcription. Considering these results, we decided to investigate the QapR-controlled 
PA5507, PA5508, and PA5509 genes to see if they were the cause of decreased PQS 
concentration in the qapR mutant strain. 
2.4.4 The qapR operon decreases PQS concentration.  
Since QapR is repressing transcription of the qapR operon, we wanted to 
determine the role played by the PA5507, PA5508, and PA5509 proteins in influencing 
PQS concentration. When we expressed these three genes from an inducible promoter 
in strain PAO1 they caused a decrease in PQS concentration to a level very similar to  
 Figure 2.4. Transcription of the qapR operon is autorepressed.
a qapR’-lacZ reporter on plasmid pLP5506 were grown for 6 h in LB medium. 
activity produced in each culture was then assayed and is presented in Miller units as 
the mean +/- SD of results from duplicate assays from three separate experiments. 
Strains are indicated below each bar: PAO1 is the wild type strain and 
PKT-QapR1. (B.) Quantitative real time
QapR1. Data are presented as fold change +/
control gene rplU (set to a value of 1) from three separate biological samples. Target 
genes are indicated below each bar.
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that produced by the qapR mutant strain (Fig. 2.6). These data suggest that at least one 
of the enzymes encoded by PA5507, PA5508, or PA5509 is responsible for the 
decrease in PQS seen in the qapR mutant strain.  
To confirm that the genes encoded by PA5507, PA5508, and PA5509 are 
responsible for decreasing PQS concentration, we constructed isogenic, in-frame 
deletion mutants for all genes of the qapR operon (qapR, PA5507, PA5508, and 
PA5509) and assessed PQS production by each strain. We found that only the qapR 
mutant strain had a change in PQS concentration when compared to the wild type strain 
PAO1 (Fig. 2.7). This result was logical since QapR represses transcription of the 
operon, and therefore effects of these mutations would be masked due to the fact that 
they are not normally expressed under repression conditions. Therefore, we constructed 
a qapR/5508 double mutant strain and assessed PQS production. Mutation of PA5508 
in the qapR mutant strain effectively restored PQS concentration to a level of that 
produced by the wild type strain PAO1 (Fig. 2.7). These data support the conclusion 
that mutation of qapR derepresses a pathway that causes a decrease in PQS 
concentration in P. aeruginosa. 
  
  
Figure 2.5. QapR directly binds the qapR promoter.
either the qapR promoter (A.) or the 
lysates containing QapR. Total protein added to each reaction is noted below the 
autoradiograph. A control lysate was prepared from 
Unbound probe is indicated by the ‘*’ symbol and probe bound by QapR is denoted by 
the ‘←’ symbol. Total binding reaction mixtures were separated on nondenaturing 
polyacrylamide gels which were dried and overlaid with X
developed after approximately 18 h of exposure. The autoradiographs depicted are 
representative of at least three independent experiments.
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-ray film. Films were 
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Figure 2.6. Expression of PA5507
concentration. The genes PA5507
promoter on plasmid p5507-09OE in wild type strain PAO1 indica
each bar. The control strain containing the parent vector pHERD20T is indicated by a 
minus (-) in the plasmid lane. After 6 h of growth in LB medium, PQS was extracted and 
quantified as described in Materials and Methods. Data are p
+/- SD of three independent experiments. The presence or 
arabinose (0.5 %) is indicated below each bar of the figure.
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2.5 Discussion 
The studies reported here are an interesting extension of the discovery by 
D’Argenio et al. that the mutation of gene PA5506 (qapR) caused P. aeruginosa 
cultures to have a decreased level of PQS (8). The original strain in which qapR had 
been mutated also had a lesion in pqsL, which caused an overproduction of PQS that 
lead to an autolytic phenotype. In this report, we show that mutation of qapR alone, 
which encodes an RpiR-family transcriptional regulator homolog, resulted in greatly 
decreased levels of PQS produced in this strain (Fig. 1A). Transcription of the PQS 
biosynthetic operon was also much lower in the qapR mutant, while transcription of 
pqsR was unaffected (Fig. 2). The PQS biosynthetic operon transcriptional activity could 
be restored in the qapR mutant by addition of PQS which suggests that PQS deficiency 
is the limiting factor (Fig. 2). In support of this theory, expression of pqsABCD restored 
PQS concentration in the qapR mutant strain (Fig. 2), while the addition of anthranilate 
did not. Taken together, these data led us to conclude that PQS precursor availability is 
not affected by the qapR mutation. 
We have shown that qapR is transcribed as the first gene in a polycistronic 
operon along with three downstream genes (Fig. 3). Our data show that transcription of 
this operon is directly repressed by QapR (Fig. 4 and 5) and that overexpression of the 
qapR operon enzymes (PA5507, PA5508, and PA5509) caused a significant decrease 
in PQS concentration in P. aeruginosa  (Fig. 6). Together, these results suggest that our 
qapR mutant acted indirectly to lower PQS levels by derepressing genes PA5507, 
PA5508, and PA5509. This implication was confirmed when our qapR/PA5508 double 
mutant restored PQS concentration back to a level similar to that produced by strain 
                                                                                                     
Figure 2.7. Mutation of quinolone alteration pathway enzymes abrogates PQS 
modulation in the ∆qapR mutant strain.
and PQS was extracted and quantified as described in Materials and Methods. Data are 
presented as the average +/- 
indicated below each bar. Strains PKT
07, PKT-QapR1-08, and PKT-
∆qapR ∆5507, ∆qapR ∆5508, and 
 
 
 
 
 
 
 
40 
 
 
 
 
 
 Cultures were grown for 18 h in LB medium 
SD of three independent experiments. Strains are 
-QapR1, PKT-07, PKT-08, PKT-09, PKT
QapR1-09 are written as ∆qapR, ∆5507, ∆
∆qapR ∆5509, respectively. 
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PAO1 (Fig. 2.7). This also explains the results seen with the single PA5507, PA5508, 
and PA5509 mutants (Fig. 2.7) because these genes are normally repressed in the wild 
type strain and therefore mutation of these genes would not change expression. The 
mechanism through which these genes affect PQS concentration is not known, but 
there are several obvious possibilities to consider. We propose that the qapR operon 
has a low, basal level of transcription as it is repressed by QapR. Derepression of the 
operon leads to expression of the PA5507, PA5508, and PA5509 genes and their 
encoded proteins which interact either directly with PQS, or with a PQS precursor that is 
downstream from anthranilate. Alternatively, the proteins encoded by genes PA5507, 
PA5508, and/or PA5509 could be directly altering PQS. Ladner et al. demonstrated that 
PA5508 encodes an enzyme that exhibits γ-glutamyl aromatic monoamine ligase 
activity in vitro [50]. This enzyme was able to glutamylate several aromatic amine 
substrates including tyramine, serotonin, and norepinephrine while tyrosine and 
tryptophan were nonsubstrates. These data can be used to support either of our above 
theories. The genes PA5507 and PA5509 are predicted to encode proteins with 
sequence homology to iso-chorismatase and amidohydrolase activity, respectively [2]. 
These putative functions do not immediately suggest a possible reaction directly 
involving quinolones because of the absence of a reactive primary amino group. 
Nonetheless, there are other possible mechanisms through which PQS production 
could be attenuated by the qapR operon enzymes. Degradation of PQS has been 
demonstrated by dioxygenolytic cleavage catalyzed by the enzyme Hod (3-Hydroxy-2-
methyl-4(1H)-quinolone 2,4-dioxygenase) from Arthrobacter spp. [84]. However, none of 
the predicted functions of genes PA5507, PA5508, or PA5509 were analogous to Hod 
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activity. Therefore, it is more likely these enzymes affect PQS concentration by 
modification of PQS or a precursor, rather than degradation of the quinolone ring. It is 
possible that the direct PQS precursor HHQ (2-heptyl-4-quinolone) is modified by these 
enzymes preventing PqsH from converting HHQ into PQS [90]. An additional possibility 
is that the qapR operon enzymes are producing a molecule that can inhibit PQS 
biosynthesis which would also be very interesting as a mechanism to ensure PQS or 
quinolones in general are not overproduced to the detriment of the cell. 
The results of this study detail a transcriptional regulator from a characterized 
family of regulators known to control genes involved in central metabolism. We have not 
investigated regulation of central metabolic genes by QapR but the possibility for it to 
regulate other genes exists. Other members of the RpiR-family of transcriptional 
regulators are most commonly associated with the repression of carbohydrate 
metabolism genes [15, 39, 47, 94]. Two RpiR-family homologs in Staphylococcus 
aureus have been demonstrated to regulate pentose phosphate pathway enzymes in 
addition to virulence genes via regulation of RNAIII synthesis [109]. This family of 
regulatory proteins may be acting as a checkpoint to virulence factor production within 
the cell. It would be advantageous for a pathogen to link synthesis of required 
biosynthetic intermediates with virulence to avoid production of virulence factors at the 
expense of central metabolism. And the qapR operon may be playing a role in 
balancing the flux of molecules routed to virulence factor production or central 
metabolism. 
We believe the knowledge gained from this study and continued investigation of 
the qapR operon enzymes could provide a new route to fighting P. aeruginosa infection. 
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Since the qapR operon can decrease PQS concentration, this implies that a novel 
mechanism to disrupt quinolone signaling exists within P. aeruginosa. If a means of 
derepressing the qapR operon in vivo is discovered, then P. aeruginosa infection 
severity may be decreased by treating with a compound that alters coordinated 
behavior instead of traditional antibiotic targets.  
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Table 2.1 Bacterial strains and plasmids used in this study. 
Strain or Plasmid Relevant genotype or 
phenotype 
Reference or source 
E. coli DH5α λ- φ80dlacZ∆M15 ∆(lacZYA-
argF) U196 recA1 endA1 
hsdR17 (rK- mK-) supE44 thi-1 
gyrA relA1 
[106] 
   
P. aeruginosa strains 
  
     PAO1 Wild type [36] 
   
     PKT-QapR1 qapR deletion mutant derived 
from PAO1 
This study 
   
     PAO1pqsR’-lacZ Wild type harboring 
chromosomal pqsR’-lacZ 
This study 
   
     PKT-QapR1pqsR’-lacZ qapR deletion mutant harboring 
chromosomal pqsR’-lacZ 
This study 
   
     PKT-07 PA5507 deletion mutant 
derived from PAO1 
This study 
   
     PKT-08 PA5508 deletion mutant 
derived from PAO1 
This study 
   
     PKT-09 PA5509 deletion mutant 
derived from PAO1 
This study 
   
     PKT-QapR1-08 qapR/PA5508 double deletion 
mutant derived from PKT-
QapR1 
This study 
   
Plasmids   
     pHERD20T E. coli/P. aeruginosa shuttle 
expression vector 
[85] 
   
     pEX18Ap Suicide vector for P. 
aeruginosa 
[34] 
   
     p∆qapR qapR deletion suicide vector This study 
   
     pqapROE PBAD-qapR on pHERD20T This study 
   
     pLP170 Transcriptional fusion vector [83] 
   
     pLP0996 pqsA’-lacZ transcriptional 
fusion 
[65] 
   
     pLP5506 qapR’-lacZ transcriptional 
fusion 
This study 
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     pPQSsynOE PBAD-pqsABCD on pHERD20T This study 
   
     pUC18-mini- 
     Tn7T-Gm-lacZ 
Chromosomal lacZ 
transcriptional fusion vector 
[10] 
   
     pTNS2 Transposase expression vector [10] 
   
     pFLP2 FLP recombinase expression 
vector 
[34] 
   
     pJF-Tn7T-pqsR’Tc pqsR’-lacZ  transcriptional 
fusion vector for chromosomal 
integration 
This study 
   
     p5507-09OE PBAD-PA5507-5509 on 
pHERD20T 
This study 
   
     p∆5507 PA5507 deletion suicide vector This study 
   
     p∆5508 PA5508 deletion suicide vector This study 
   
     p∆5509 PA5509 deletion suicide vector This study 
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Table 2.2 Primers used in this study. 
Primer  Sequence (5’→3’)a 
qapR Expression 
 
     5506OE Up1 AAATCTAGAATGCAAGAACTAAAACAACGC 
     5506OE Down1 AAAAAGCTTGTTCTCGTCCACTGCGCGCAT 
  
qapR Mutation 
 
     5506 Up1 AAAGGATCCGCTGATCCTCGTCCAGATTC 
     5506 Up2 CGTGCCCTGCTCGATGACTACAACGCGTTCAGCAGTCATATT 
     5506 Down1 AATATGACTGCTGAACGCGTTGTAGTCATCGAGCAGGGCACG 
     5506 Down2 AAAGGATCCTGCTCTCGTCGATCAGGTC 
  
qapR Operon RT-
PCR 
 
     5506-1 AATCCGCCTCGCCCTTCGAC 
     5507-1 GTTCTGCACGCGCTCGTAGAA 
     5507-2 TGCCGCCGACCGCGGTTA 
     5508-1 AGGTCCTGCGGGGTCAGCGA 
     5508-2 GGACACCTACCTCGCCATGA 
     5509-1 AAAGCTCTTCGGCCAGCGC 
     5509-2 GTTCCGGTGCATGGCGACGC 
     5510-1 TGCCCACCAGGTAGGCCATC  
  
EMSA Probes  
     5506 EMSA 1 AAGCCGCGTAACCGCCCC 
     5506 EMSA 2 GGGGCATCCTCGAAGGTGGG 
  
     pqsA EMSA 1 TGTAACGGTTTTTGTCTGGC 
     pqsA EMSA 2 GACAGAACGTTCCCTCTTCA 
  
PQS Operon 
Expression 
 
     PQS syn 1 AAAAACCATGGATGTCCACATTGGCCAACCT 
     PQS syn 2 AAAAATCTAGAACCGAGACGCAGCAGGAA 
  
qapR’-lacZ 
Reporter 
 
     5506placZ 1 AAAAAAAGCTTCAAAGGCGCGGTGGTACCGG 
     5506placZ 2 AAAAATCTAGAGCACCACCTTGCGCTCCG 
  
Quantitative Real 
Time-PCR 
 
     5507 qRT 1 GTTCAGCCTGCCCCACCACT 
     5507 qRT 2 TTCTCGTCCACTGCGCGCAT 
     5508 qRT 1.2 CTGGGCAAGCAGTACAACCT 
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     5508 qRT 2.2 GGATCGACATCGGCCAGG 
     5509 qRT 1 GCGGCGGAAGAACACATCGC 
     5509 qRT 2 TCTCGGACAGCTCGCGGTTG 
     RplU_rt_1 GGTGGCAAGCAGCACAAAGTCACCG 
     RplU_rt_2 GCGGACCTTGTCGTGACGGCCGTGG 
  
PA5507-5509 
Expression 
 
     PA5507-09 Ex 1 AAAAACCATGGATGTTCAGCCTGCCCCACCA 
     PA5507-09 Ex 2 AAAAAAAGCTTACGGGCTCCTCGGGAAAAGG 
  
pqsR’-lacZ 
Chromosomal 
Reporter 
 
     pqsR lacZ Tc 1 AAAAACTGCAGACCAGGAGTCGTTTCGGAAAT 
     pqsR lacZ Tc 2 AAAAAAAGCTTGCAGCGGAGGAAATCGAACCG 
  
PA5507 Mutation  
     5507 Up-1 AAAAATCTAGACGTCTGCCTGCCGTGCCACG 
     5507 Up-2 GGCGATGCGTTGCAGGACGGTGGTCTGCCGGCGGCCGAAT 
     5507 Down-1 ATTCGGCCGCCGGCAGACCACCGTCCTGCAACGCATCGCC 
     5507 Down-2 AAAAATCTAGACTTCGCGGTTGCGCAGTCCC 
  
PA5508 Mutation  
     5508 Up-1 AAAAATCTAGAGCCAGGCCCAGCACGTGG 
     5508 Up-2 CGTCAGCGCCAGTTCGTGGCGCAGGGGCAGCGAACGCCC 
     5508 Down-1 GGGCGTTCGCTGCCCCTGCGCCACGAACTGGCGCTGACG 
     5508 Down-2 AAAAATCTAGACAGCCGTAGACCCCGAACGG 
  
PA5509 Mutation  
     5509 Up-1 AAAGGATCCGTTCGAACACGAATTCAGCC 
     5509 Up-2 TCCATCGTTGCGGATCTCCCAGGCGATGTGTTCTTC 
     5509 Down-1 GAAGAACACATCGCCTGGGAGATCCGCAACGATGGA 
     5509 Down-2 AAAGGATCCAGTGGTTGATCACGCTCA 
aUnderlined sequence denotes restriction site utilized for cloning. 
  
  
 
CHAPTER THREE: TRANSLATIONAL COUPLING PROTECTS PSEUDOMONAS 
QUINOLONE SIGNAL PRODUCTION IN PSEUDOMONAS AERUGINOSA 
3.1. Summary 
Pseudomonas aeruginosa can sense and respond to a myriad of environmental 
signals and utilizes a system of small diffusible molecules to communicate through 
intercellular signaling. The small molecule 2-heptyl-3-hydroxy-4-quinolone 
(Pseudomonas Quinolone Signal [PQS]) is one of these signals and its synthesis is 
important for virulence. Previously, we identified an RpiR-type transcriptional regulator, 
QapR (PA5506), that modulates PQS production by repressing the qapR operon, which 
is capable of reducing PQS concentration through an unknown mechanism. In this 
study, we report that QapR translation is linked to the downstream gene PA5507, which 
provides another layer of regulation to protect quinolone production. A point mutation in 
qapR that introduced a premature stop codon alleviated transcriptional repression of the 
qapR operon but did not negatively affect PQS concentration as expected. This was 
investigated with a series of lacZ reporter fusions which showed that translation of 
QapR must terminate at, or close to, the natural qapR stop codon in order for translation 
of PA5507 to occur. This regulation was partially alleviated by altering the PA5507 
ribosome binding site, which supports the hypothesis that PA5507 is not independently 
translated. Considering these findings, we propose that an inverse correlation between 
PA5507 translation and PQS concentration exists. 
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3.2 Introduction 
The gram negative bacterium Pseudomonas aeruginosa is a well-known 
opportunistic pathogen of humans that can infect a broad range of hosts  [16, 87, 97]. 
This organism can cause significant morbidity and mortality in immunocompromised 
individuals as well as those afflicted with cystic fibrosis where P. aeruginosa can 
establish intractable infections in the lungs [21, 31]. P. aeruginosa is able to adapt to a 
wide range of niches due to its ability to respond to environmental stimuli through a 
network of transcription factors, two-component systems, and intercellular signaling 
networks [3]. 
In P. aeruginosa, three interconnected signaling systems regulate a battery of 
virulence factors and other cellular functions [74, 75, 79]. The las and rhl systems 
produce and respond to homoserine lactone signaling molecules and are true quorum 
sensing systems  [18, 26]. The third signaling system produces and responds to the 
small molecule 2-heptyl-3-hydroxy-4-quinolone (the Pseudomonas quinolone signal 
[PQS]) [79]. This signaling system is positively regulated by the las quorum sensing 
system and negatively regulated by the rhl quorum sensing system [6, 30, 65]. PQS is 
produced from the precursor molecules anthranilate, malonyl-CoA, and octanoyl-CoA 
through the action of enzymes encoded by the genes pqsABCD and pqsH [8, 14, 22, 
90]. PQS, one of 56 quinolone molecules produced by P. aeruginosa  [55], then 
interacts with the transcriptional regulator PqsR, which activates transcription of the 
PQS biosynthetic operon (pqsABCDE) in a positive autoregulatory loop [99]. The last 
gene of the biosynthetic operon, pqsE, is required for producing the response to PQS, 
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which includes increased production of the virulence factors pyocyanin, rhamnolipid, 
and elastase [25]. 
Our previous study detailed a transcriptional regulator that represses an operon 
that negatively affects PQS concentration in P. aeruginosa [98]. QapR encodes an 
RpiR-type regulator that is the first gene of a four gene operon containing itself, 
PA5507, PA5508, and PA5509 (PA5507-PA5509 are required to reduce PQS 
concentration). The mechanism for this reduction is unknown, but PA5507 has 
sequence homology to isochorismateses, PA5508 has homology to glutamine 
synthetases but functions in-vitro as a monoamine ligase [50], and PA5509 has 
sequence homology to amidohydrolases. Unfortunately, these putative functions do not 
indicate an obvious reaction that would directly affect quinolones. Our initial studies 
indicated transcriptional repression of the qapR-led operon but we suspected more 
intricate regulation due to the disparity in PQS concentration produced by two different 
qapR transposon mutants. The qapR insertion mutant from D’Argenio et al. [14] has an 
insertion in the 3’ half of the gene and yielded significantly reduced PQS concentration 
while the qapR transposon mutant from the PA14 Non-Redundant library had a 
transposon inserted into the 5’ half of the gene, which had no effect on PQS 
concentration [57].  
One mechanism of controlling the expression of genes within polycistronic 
operons is translational coupling. This occurs when translation of a preceding gene 
affects translation of a downstream gene, as has been shown for trpE-trpD in 
Escherichia coli [72]. These two genes are transcribed as part of a polycistronic operon 
and premature termination of TrpE translation has a significant negative effect on TrpD 
 51 
 
translation. Several other studies have shown that translational coupling can serve as a 
powerful regulatory mechanism for controlling protein stoichiometry of polycistronic 
transcripts in prokaryotes and bacteriophage [38, 91]. In this report, we present data 
which shows that qapR is translationally coupled to PA5507 and this coupling provides 
a secondary layer of regulation to protect PQS signaling in P. aeruginosa. 
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3.3 Experimental Procedures 
3.3.1 Bacterial strains, plasmids, and growth conditions.  
Bacterial strains used in this study are listed in Table 1. Strains of P. aeruginosa 
and Escherichia coli were maintained at -70oC in 10% skim milk (Becton, Dickinson) 
and 15% glycerol, respectively. Bacteria were freshly plated from frozen stocks to begin 
each experiment and were grown in Luria-Bertani (LB) medium as noted below [89]. 
When required to maintain plasmids, cultures were supplemented with 200 µg ml-1 of 
carbenicillin for P. aeruginosa and 100 µg ml-1 of ampicillin for E. coli. L-Arabinose 
(Sigma-Aldrich) was added to cultures to induce expression of genes under the control 
of the PBAD promoter where indicated. 
Plasmids used in this study are listed in Table 1. To generate an expression 
plasmid for PA5507, a 688 bp DNA fragment, which began at the PA5507 start codon 
and ended 34 bp downstream from the stop codon, was amplified by PCR using 
chromosomal DNA from strain PAO1 as a template. The oligonucleotide primers used 
for PCR were engineered to include an NcoI site upstream from the start codon and an 
XbaI site downstream from the stop codon. The purified PCR fragment was digested 
with these enzymes and was ligated into vector plasmid pHERD20T [85], which 
contains a PBAD promoter to control gene expression and a ribosome binding site for 
translation initiation. This produced the PBAD-PA5507 expression plasmid p5507Exp. A 
similar strategy was used to generate expression plasmids for PA5508 and PA5509. 
For PA5508, a 1,438-bp DNA fragment, which began at the PA5508 start codon and 
ended 106 bp downstream from the stop codon, was amplified by PCR with primers 
engineered to include an NcoI site upstream from the start codon and a HindIII site 
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downstream from the stop codon. The purified fragment was digested and ligated into 
pHERD20T. This produced the PBAD-PA5508 expression plasmid p5508Exp. For 
PA5509, a 769 bp DNA fragment, which began at the PA5509 start codon and ended 
100 bp downstream from the stop codon, was amplified by PCR with primers 
engineered to include an NcoI site upstream from the start codon and a HindIII site 
downstream from the stop codon. The purified fragment was digested and ligated in 
pHERD20T. This produced the PBAD-PA5509 expression plasmid p5509Exp. 
To generate a qapR-07’(C90G)-lacZ reporter plasmid, a 1,178-bp DNA fragment 
corresponding to bp -230 from the qapR start codon to bp +86 relative to the PA5507 
start codon was amplified via PCR using chromosomal DNA from strain PKT-QapR-
C90G as a template. Primers were engineered to include an EcoRI site and a BamHI 
site upstream and downstream from the fragment, respectively. Purified PCR fragments 
were digested and ligated into pSW205 [102] to produce the plasmid pqapR-07’ 
(C90G)/SW205, which harbors the natural qapR promoter, the qapR-C90G point mutant 
gene and a fragment of PA5507 translationally fused to the lacZ gene. The ∆qapR-07’-
lacZ reporter plasmid was generated using the same primers as the point mutant 
reporter but with ∆qapR chromosomal DNA as template. This plasmid contains a 443-
bp DNA fragment corresponding to bp -230 from the qapR start codon to +86 bp relative 
to the PA5507 start codon. The purified and digested fragment was ligated into pSW205 
to produce plasmid p∆qapR-07’/SW205, which harbors the natural qapR promoter, the 
∆qapR deletion mutant gene and a fragment of PA5507 translationally fused to the lacZ 
gene. 
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To generate a qapR’-lacZ reporter plasmid controlled by the foreign PlacUV5 
promoter, an 85-bp DNA fragment corresponding to bp -17 to bp +68 relative to the 
qapR start codon was amplified via PCR using chromosomal DNA from strain PAO1 as 
a template. Oligonucleotide primers were engineered to include an EcoRI site and the 
PlacUV5 promoter (40 bp comprising -35 and -10 sequences) upstream from the 
transcriptional start site and a BamHI site downstream from the fragment. The purified 
PCR product was digested with these enzymes and was ligated into pSW205 to 
produce the plasmid pqapR’lacUV5/SW205. This plasmid harbors the foreign PlacUV5 
promoter fused to the qapR transcriptional start site and a fragment of qapR 
translationally fused to the lacZ gene. 
To generate a qapR-07’-lacZ reporter plasmid controlled by the foreign PlacUV5, a 
965 bp DNA fragment corresponding to bp -17 relative to the qapR start codon to bp 
+86 relative to the PA5507 start codon was amplified via PCR using chromosomal DNA 
from strain PAO1 as template. Oligonucleotide primers were engineered to include an 
EcoRI site and the PlacUV5 promoter upstream from the qapR transcriptional start site 
and a BamHI site downstream from the fragment. The purified PCR product was 
digested with these enzymes and was ligated into pSW205 to produce the plasmid 
pqapR-07’lacUV5/SW205. This plasmid harbors the foreign PlacUV5 promoter fused to 
the qapR transcriptional start site, the qapR gene, and a fragment of PA5507 
translationally fused to the lacZ gene. A similar plasmid,   pqapR-07’ 
(C90G)lacUV5/SW205, was generated via PCR using the same primers as above and 
chromosomal DNA from the qapR-C90G point mutant as template. This plasmid 
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contains the foreign PlacUV5 promoter fused to the qapR transcriptional start site, the 
qapR-C90G gene, and a fragment of PA5507 translationally fused to the lacZ gene. 
To generate a qapR-07’(C651G)-lacZ reporter plasmid controlled by the foreign 
PlacUV5 promoter, a 965 bp DNA fragment corresponding to bp -17 relative to the qapR 
start codon to bp +86 relative to the PA5507 start codon was amplified via PCR with 
chromosomal DNA from strain PAO1 as template. To introduce the C651G mutation, 
two fragments of 668 bp and 297 bp were amplified via PCR with primers that were 
engineered to contain an EcoRI site and the PlacUV5 promoter and the C651G base 
mutated upstream and downstream from the 668 bp fragment, respectively. The 297 bp 
fragment was amplified with primers engineered to contain a BamHI site downstream 
from the fragment. Purified PCR product was ligated to produce the full-length fragment 
and was gel purified. This purified fragment was then digested with BamHI/EcoRI and 
ligated into pSW205 to produce plasmid pqapR-07’ (C651G)lacUV5/SW205. This 
plasmid harbors the foreign PlacUV5 promoter fused to the transcriptional start site of 
qapR, the qapR-C651G gene, and a fragment of PA5507 translationally fused to the 
lacZ gene. A similar plasmid, pqapR-07’(G805T)lacUV5/SW205, was generated via a 
similar technique as above. Briefly, two fragments of 821 bp and 144 bp were amplified 
via PCR with primers engineered to include an EcoRI site and the PlacUV5 promoter 
upstream from the 821 bp fragment. The 144 bp fragment was amplified with primers 
engineered to contain the G805T mutation and a BamHI site upstream and downstream 
from the fragment, respectively. This plasmid harbors the PlacUV5 promoter fused to the 
qapR transcriptional start site, the qapR-G805T gene and a fragment of PA5507 
translationally fused to the lacZ gene.  
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To generate a qapR-07’(RBS mutation)-lacZ reporter plasmid controlled by the 
PlacUV5 promoter, a 965 bp DNA fragment corresponding to bp -17 relative to the qapR 
start codon to bp +86 relative to the PA5507 start codon was amplified via PCR using 
chromosomal DNA from strain PAO1 as template. To introduce the RBS mutation, two 
fragments of 867 bp and 98 bp were amplified using oligonucleotide primers engineered 
to include an EcoRI site and the PlacUV5 promoter upstream from the 867 bp fragment. 
The 98 bp fragment was amplified by primers that were engineered to mutate the 
putative PA5507 RBS sequence of AGGAA to TTTTT upstream from the fragment and 
a BamHI site downstream from the fragment. These fragments were purified and ligated 
to produce the full length fragment. Full length fragment was digested and ligated into 
pSW205 to produce the plasmid pqapR-07’(RBS-mut)lacUV5/SW205 which harbors the 
PlacUV5 promoter fused to the qapR transcriptional start site, the qapR gene, and gene 
PA5507 that has a mutated RBS translationally fused to the lacZ gene. 
All plasmids were transformed into P. aeruginosa by electroporation as described 
by Choi and Schweizer [11]. All plasmids and constructed fusions were confirmed by 
DNA sequencing. 
 
3.3.2 Generation of mutants.  
Mutant P. aeruginosa strains were generated as described previously by Hoang 
et al. [34]. The qapR-C90G point mutant allele was constructed by amplification of a 
2812 bp DNA fragment including flanking sequence (~1000 bp upstream and 
downstream from qapR) using chromosomal DNA from strain PAO1. Oligonucleotide 
primers were engineered to include HindIII sites up and downstream from the fragment. 
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Purified fragment was digested with HindIII and ligated into pEX18Ap which had been 
digested with HindIII to produce pqapR-large frag. This plasmid was purified and utilized 
as template for inverse PCR with 5’-phosphorylated primers to mutate qapR bp +90 
from C to G (which will convert codon 30 (TAC) from tyrosine to a stop codon (TAG)). 
Inverse PCR product was purified and self-ligated to produce the suicide vector pqapR-
C90G. The ∆qapR-RBS-mut allele was constructed by amplification of a 2077 bp DNA 
fragment from ∆qapR chromosomal DNA with primers engineered to include HindIII 
sites up and downstream from the fragment. To introduce the RBS mutation, two 
fragments of 1243 bp and 834 bp were amplified via PCR with primers engineered to 
mutate the putative PA5507 RBS from AGGAA to TTTTT. These two fragments were 
gel purified and ligated to produce the 2077 bp fragment ∆qapR-RBS-mut allele which 
was digested and ligated into pEX18Ap that had also been digested to produce 
p∆qapR-RBS-mut. The ∆qapR-C651G allele was constructed by amplification of a 
2,256 bp DNA fragment using chromosomal DNA from strain PAO1. Oligonucleotide 
primers were engineered to include HindIII sites up and downstream from the fragment. 
To introduce the C651G mutation, two fragments of 1,218 bp and 1,038 bp were 
amplified with primers engineered to introduce the C651G mutation upstream from the 
1,038 bp fragment. Purified fragments were ligated to produce the full length ∆qapR-
C651G mutant allele. This fragment was digested with HindIII and ligated into pEX18Ap 
that had also been digested to produce plasmid p∆qapR-C651G. The ∆qapR-G805T 
allele was constructed by amplification of a 2,097 bp DNA fragment using chromosomal 
DNA from strain PAO1. Oligonucleotide primers were engineered to include HindIII sites 
up and downstream from the fragment. To introduce the G805T mutation, two 
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fragments of 1,218 bp and 879 bp were amplified with primers engineered to introduce 
the G805T mutation upstream from the 879 bp fragment. Purified fragments were 
ligated to produce the full length ∆qapR-G805T mutant allele. This fragment was 
digested with HindIII and ligated into pEX18Ap that had also been digested to produce 
plasmid p∆qapR-G805T. To transfer the mutant alleles onto the P. aeruginosa PAO1 
chromosome, the plasmid was electroporated into cells and integrants were selected as 
described by Choi and Schweizer (2006). Potential mutants were screened by PCR 
using appropriate primers and DNA sequencing to ensure that the mutations had been 
transferred to the chromosome. 
 
3.3.3 Assay for PQS quantification.  
To assay for PQS production, bacteria from frozen milk stocks were grown on LB 
agar with antibiotics as necessary. Isolated colonies were used to inoculate 2 ml LB 
broth cultures supplemented with antibiotics and L-arabinose where noted and were 
incubated at 37oC with vigorous shaking for 5 or 18 h, as noted in figure legends. PQS 
was extracted as described by Calfee, Coleman, and Pesci [8] and PQS extracts were 
visualized under long-wave UV light and photographed as described by D’Argenio et al. 
[14]. Images were then analyzed using QuantityOne software (Bio-Rad) to quantify PQS 
by densitometry. 
 
3.3.4 β-Gal assays in P. aeruginosa.  
Cells from overnight cultures were washed in LB broth and used to inoculate 2 ml 
LB broth cultures supplemented with appropriate antibiotics to an optical density at 660 
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nm (OD660) of 0.05. Cultures were incubated at 37oC with vigorous shaking. At 6 h, 
aliquots were collected and β-galactosidase (β-Gal) activity was assayed in duplicate. 
Activity is reported in Miller units as the mean ± standard deviation of at least three 
separate experiments [66]. 
 
3.3.5 RNA isolation.  
Washed cells from overnight cultures of strains PAO1, PKT-QapR-C90G, and 
PKT-QapR1 p∆qapR-07’/SW205 were used to inoculate 10 ml LB broth cultures, 
supplemented with antibiotics as necessary, to an OD660 0.05. Cultures were incubated 
at 37oC with shaking for 3 h (OD660 ~1.5) for strains PAO1 and PKT-QapR-C90G or for 
6 h (OD660 >~3) for strain PKT-QapR1 (p∆qapR-07’/SW205) prior to treatment with 
RNAprotect (Qiagen) following the manufacturer’s protocol. Cells were collected by 
centrifugation at 6,000 x g for 10 min at 4oC, and total cellular RNA was isolated from P. 
aeruginosa cells using the RNeasy Midiprep kit according to the manufacturer’s protocol 
(Qiagen). Contaminating DNA was removed by treatment of RNA samples with RQ1 
RNase-Free DNase according to the manufacturer’s protocol (Promega). RNA was then 
extracted with 1:1 phenol-chloroform and collected by ethanol precipitation. Purified 
RNA was resuspended in nuclease-free water and was quantified with a NanoDrop ND-
1000 spectrophotometer (Thermo-Scientific).  
 
3.3.6 cDNA synthesis for quantitative real-time PCR.  
Total RNA from strains PAO1 and PKT-QapR-C90G were isolated and purified 
as above. cDNA was synthesized in a 21 µl reaction volume from 5 µg of total RNA 
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using a 1:1 mixture of GC-rich hexamers (Gene Link) and random hexamers 
(Invitrogen) for priming with 40 µM deoxynucleoside triphosphates (dNTPs)(USB). 
Reactions were then heated to 65oC for 5 min, followed by cooling to 4oC for 1 min. 
Following this step 200 U of SuperScript III reverse transcriptase in First Strand Buffer 
(Invitrogen) with dithiothreitol and RNase Out RNase Inhibitor (Invitrogen) was added to 
each reaction mixture, yielding a final volume of     30 µl. Reaction mixtures were then 
heated to 25oC for 5 min, followed by 50oC for 60 min and then 75oC for 15 min. 
 
3.3.7 Quantitative real-time PCR.  
cDNA and total RNA to be used as the template and negative control, 
respectively, were diluted 1:50 in nuclease-free water. Oligonucleotide primer pairs for 
qRT-PCR were generated by the Primer-BLAST program 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Primers were designed to amplify a 
200 bp fragment of rplU (control), a 213 bp fragment of PA5507, a 140 bp fragment of 
PA5508, and a 199 bp fragment of PA5509 as target genes. qRT-PCR was performed 
using FastStart SYBR green master mix (Roche Diagnostics) with a Bio-Rad CFX96 
cycler. The following cycle was utilized to amplify and quantify fragments: 95oC for 10 
min and then 95oC for 15 s, 55oC for 15 s, and 72oC for 20 s, repeated 40 times. Melt 
curve data were collected to ensure amplification of one fragment by heating samples 
from 65oC to 95oC in 0.5oC increments. Data were generated from three separate RNA 
and cDNA preparations and at least two technical replicates for each primer set. 
Relative expression of each gene was determined by comparing target genes with the 
control gene (rplU) using the Pfaffl method [81].  
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3.3.8 Primer extension.  
RNA was extracted and purified from strain PKT-QapR1 p∆qapR-07’/SW205 as 
described above. Plasmid p∆qapR-07’/SW205 was included in order to improve the 
extension process by increasing the number of copies of qapR mRNA present. Two 
primers were used in separate primer extension experiments:   5’-
GGCGTCAGTTCGGCGGGCGG-3’ corresponding to bp +31 to +50 relative to the qapR 
start codon was annealed at 55oC, and 5’-TAGTCATCGAGCAGGGCACGCAC-3’ 
corresponding to bp +67 to +89 relative to the qapR start codon was annealed at 45oC. 
These primers were radioactively labeled using [γ-32P]ATP (Perkin-Elmer) and T4 
Polynucleotide kinase (New England Biolabs). Primer extension reactions were carried 
out as described previously by Pearson et al. [76] using 40 µg RNA and SuperScript III 
reverse transcriptase (Invitrogen). DNA sequencing ladders were prepared using the 
ThermoSequenase Cycle Sequencing kit (USB) using oligonucleotide primers utilized 
for extension reactions and p∆qapR-07’/SW205 as template. Extension and sequencing 
reactions were resolved on 8M urea, 8% polyacrylamide gels. Dried gels were 
visualized by autoradiography.  
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3.4 Results 
3.4.1 A premature stop codon in qapR does not affect PQS concentration. 
Previously, we showed that deletion of the transcriptional regulator gene qapR 
from P. aeruginosa had a negative effect on PQS concentration [98]. We found that 
deletion of qapR prevented transcriptional auto-repression of the qapR operon and 
allowed for overexpression of the downstream genes PA5507, PA5508, and PA5509, 
which led to decreased PQS concentration by an unknown mechanism. Since PQS is 
important for virulence, and modulation of its production could be beneficial to reducing 
infection severity, we wanted to further investigate the regulatory mechanism controlling 
the qapR operon. We initially hypothesized that the qapR ORF encoded a negative 
regulatory element, which was deleted in the ∆qapR mutant. This idea was developed 
while considering the PQS concentration produced by two different qapR transposon 
mutants. The transposon mutant 64R2 was found to suppress autolysis in a PQS 
overproducing mutant [14]. This mutant contained an insertion 649 bp downstream from 
the qapR translational start and displayed reduced PQS concentration. The other qapR 
transposon mutant was obtained from the PA14 Non-Redundant Insertion Mutant 
Library [57] and has an insertion 11 bp downstream from the qapR translational start 
codon. No reduction in PQS concentration was seen with this insertion. This led us to 
speculate that there existed a regulatory element within qapR that modulated 
expression of the downstream genes of the qapR operon. 
In order to investigate this hypothesis, we constructed a P. aeruginosa strain that 
carried a point mutation which introduced a premature stop codon in qapR (referred to 
as strain PKT-QapR-C90G). This mutation altered base 90 of the qapR coding 
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sequence which converted a tyrosine codon (TAC; amino acid 30 out of 286) to a stop 
codon (TAG) while preserving the remainder of the qapR coding sequence. As 
expected, this mutant was similar to the ∆qapR deletion mutant with regard to 
transcriptional activity from the qapR promoter. β-gal activity from the qapR’-lacZ 
reporter fusion was increased in both mutant strains compared to the wild type strain 
PAO1 (Fig. 1A). This derepression was confirmed with quantitative real-time PCR that 
assessed the relative transcript level of the genes downstream from qapR in the qapR 
operon. We found, similar to the ∆qapR deletion mutant, that all three genes of the 
qapR operon were expressed several fold higher in the qapR-C90G point mutant 
compared to the wild type strain PAO1 (Fig. 1B). Because of this, we expected that 
PQS concentration from strain qapR-C90G would be decreased, but this was not the 
case. The point mutant showed no reduction in PQS concentration when compared to 
strain PAO1 (Fig. 2). Both the qapR-C90G point mutant and strain PAO1 produce 
approximately 3 times more PQS than the ∆qapR deletion mutant strain. These data 
indicated that a negative regulatory element was not present but that regulation of this 
operon was more complex than simple transcriptional repression by QapR.  
 
3.4.2 PA5507 expression is required to decrease PQS concentration.  
Since PQS concentration was unaffected by premature termination of qapR 
translation, but transcription of the qapR operon was increased, we wanted to 
investigate possible deficiencies in the expression of the functional enzymes of the 
qapR operon (PA5507, PA5508, and PA5509). Previously, it was shown that 
overexpression of PA5507, PA5508, and PA5509 together from an inducible promoter  
 Fig. 3.1. Premature termination of 
(A) Strains carrying a qapR’-lacZ
in LB medium. β-gal activity was then assayed and is presented in Miller units as the 
mean ± SD of results from duplicate a
are indicated below each bar. (B) Quantitative real
PAO1 (wild-type) and PKT-QapR
in strain PKT-QapR-C90G to the expression
biological samples. Target genes are indicated below each bar.
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could reduce PQS concentration in strain PAO1 [98]. To determine the effects of 
individual genes, we constructed expression vectors with each gene controlled by an 
inducible promoter. This allowed us to assess the effects of overexpression of each 
protein on PQS concentration in the qapR-C90G point mutant. We utilized this mutant 
because the qapR operon is overexpressed at the transcriptional level but PQS is 
unaffected which indicates a deficiency in the potential pathway catalyzed by PA5507, 
PA5508, and PA5509 (Fig. 1). We found that expression of only PA5507 was necessary 
for reducing PQS concentration in the qapR-C90G point mutant, while expression of 
PA5508 or PA5509 had no effect on PQS concentration (Fig. 3). This result indicates 
that PA5507 expression may be the limiting factor with regards to reducing PQS 
concentration in the qapR-C90G point mutant.  
 
3.4.3 Translation of gene PA5507 is coupled to qapR translation.  
In order to investigate translation of PA5507, we constructed reporter fusions that 
included the natural qapR promoter and contained either the qapR-C90G point mutant 
or the ∆qapR deletion mutant allele, with the PA5507 coding sequence translationally 
fused to the lacZ gene (see diagram in Fig. 4). The ∆qapR deletion mutant fusion 
contains the natural start and stop codons for qapR while the qapR-C90G fusion has 
the natural start codon and a premature stop codon upstream from the natural stop 
codon in qapR. This allowed us to analyze the effect of premature QapR translational 
termination on PA5507 translation. As can be seen in Figure 4, translation of PA5507 is 
approximately 7-fold higher with the ∆qapR deletion mutant allele present compared to 
the qapR-C90G point mutant allele fusion. These data indicated that prematurely  
 Fig. 3.3. Expression of gene 
when qapR translation is terminated prematurely.
PA5509 were expressed from an inducible promoter on plasmids p5507Exp, p5508Exp, 
or p5509Exp in strain PKT-QapR
(+) or without (-) 1% L-arabinose. PQS was extracted and quantified as described in 
Experimental Procedures. Data are presented as the mean ± SD of three independent 
experiments. 
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Fig. 3.4. Translation to the natural 
Wild-type strain PAO1 carrying either a 
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stopping QapR translation causes a large decrease in PA5507 translation. These 
assays were performed in strain PAO1 and the fusions should have the same relative 
rate of transcription based on being driven by the natural promoter. However, since 
mutations in QapR also affect regulation of transcription from the qapR promoter, we 
decided to investigate translation of PA5507 from a foreign promoter to reduce any 
effects of transcriptional variation. 
In order to examine translation of PA5507 without transcriptional variation, we 
first identified the transcriptional start site for the qapR operon using primer extension 
analysis. These experiments showed a single transcriptional start site for the qapR 
operon (Fig. 5A). This site was located at -17 bp relative to the qapR translational start 
codon and was confirmed by repeating the experiment with a second primer in a 
separate extension reaction and obtaining the same result (data not shown). With this 
information, we constructed a series of translational fusion reporters driven 
transcriptionally by the lacUV5 promoter [17]. The lac operator sequence was not 
included since P. aeruginosa does not encode lacI and we were not concerned with 
inducible transcription.  
We found introduction of the qapR-C90G mutation reduced PA5507 translation 
by approximately 80% and a similar reduction was evident when the stop codon was 
moved further downstream into the qapR coding sequence with the C651G mutation 
(Fig. 5B). This mutation converted a tyrosine codon (TAC) to a stop codon (TAG) and is 
approximately 75% into the qapR coding sequence. However, when we introduced a 
stop codon that allowed for the translation of greater than 90% of the qapR coding 
sequence (G805T), we saw a reduction in PA5507 translation of less than 15%.  
 Fig. 3.5. Translation of gene 
extension analysis of qapR operon transcript. Sequencing reaction mixtures are labeled 
according to nucleotide (A, T, C, G) and lane ‘Ext’ contains the mixture for the primer 
extension reaction performed with RNA harvested from a 6 h culture of strain 
harboring a ∆qapR’-lacZ translational fusion plasmid. The 
denoted as ‘A (qapR +1)’. Sequencing reactions were exposed for 18 h and primer 
extension products were exposed for 1 week. (B) Wild
translational fusion plasmids driven by the foreign 
medium for 6 h. Reporter fusions are indicated below each bar and depicted 
schematically below the figure
octagons. Data are represented as the mean ± SD of results from duplicate assays from 
three separate experiments. 
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Together, these results indicated that translation of PA5507 is coupled to the translation 
of the upstream protein QapR. They also suggest that when the ribosome complex 
approaches the qapR stop codon, translation of PA5507 is permitted. 
 
3.4.4 Premature termination of qapR translation protects PQS concentration.  
On the P. aeruginosa PAO1 chromosome, qapR and PA5507 are separated by a 
4-bp intergenic region (Fig. 6A). A putative ribosome binding site (RBS) AGGAA is 
located 7 bp upstream from the PA5507 start codon [93]. We examined the effect of 
mutating the RBS on PA5507 translation by changing the site from AGGAA to TTTTT 
within the PA5507 translational lacZ fusion driven by the lacUV5 promoter. This 
mutation reduced PA5507 translation by approximately 90% which indicates that this is 
a functional RBS for PA5507 translation (Fig. 6B). Although this mutation reduced 
PA5507 translation significantly, activity was not completely abolished as would be 
expected if the RBS was the only source of translation initiation for PA5507. This 
suggests that there is a small amount of ribosomal re-initiation from ribosomes that 
have been terminated at the qapR stop codon. It has been shown that ribosomes may 
remain bound to mRNA following translational termination to scan for nearby 
translational start sites [1]. Therefore, since qapR and PA5507 have their respective 
stop and start codons in close proximity, re-initiation could explain the low-level PA5507 
translation of the RBS mutant in Fig. 6B.  
 We sought to confirm the results of reporter fusion experiments in vivo by 
introducing premature stop and RBS mutations into the P. aeruginosa chromosome. We 
then assessed the effects that these mutations would have on PQS concentration. The  
 Fig. 3.6. Premature termination of 
(A) Intergenic region between 
underlined. Mutated RBS nucleotides are shown below the putative RBS. The 
stop codon nucleotides and the 
type strain PAO1 carrying translational fusion plasmids dr
promoter were grown in LB medium for 6 h. Reporter fusions are indicated below each 
bar and data are represented as the mean ± SDs of results from duplicate assays from 
three separate experiments. (C) Strains carrying a 
pLP5506 were grown for 6 h in LB medium. 
presented in Miller units as the mean ± SD of results from duplicate assays from three 
separate experiments. Strains are indicated below each bar. (
for 6 h in LB medium and PQS was extracted and quantified as described in 
Experimental Procedures. Data are presented as the mean ± SD of three independent 
experiments. Strains are indicated below each bar.
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premature stop codon mutations and the RBS mutation were added to the chromosome 
of the ∆qapR deletion mutant allele to ensure that the qapR operon would be 
overexpressed to mimic the ∆qapR deletion mutant, which overexpresses the qapR 
operon. Activity from the qapR promoter is increased in all mutant strains compared to 
strain PAO1 which indicates that the qapR operon is overexpressed in all mutant strains 
(Fig. 6C). Figure 6D shows that mutation of the PA5507 RBS or premature termination 
of QapR translation at codon 217 (C651G), distal to the PA5507 start codon, only 
reduced PQS concentration slightly compared to strain PAO1. However, when QapR 
translation was terminated proximally to the PA5507 translational start at codon 269 of 
QapR (G805T) PQS concentration was reduced to approximately 50% of that seen from 
strain PAO1 (Fig. 6C). These data confirm that PA5507 translation is intimately linked to 
translation of the regulator QapR in P. aeruginosa. 
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3.5 Discussion 
The studies reported here are a continuation of our work detailing the effects of 
mutating the transcriptional regulator qapR on PQS concentration in P. aeruginosa [98]. 
In this report, we show that transcriptional repression by QapR is not the sole regulation 
mechanism for the genes encoded downstream from qapR in the qapR operon 
(PA5507, PA5508, and PA5509). When translation of QapR was prematurely 
terminated by the introduction of a stop codon, PQS concentration was unaffected even 
though transcription of the qapR operon was increased (Fig. 1 & 2). This led us to 
assess translation of PA5507, PA5508, and PA5509 since we had previously shown the 
necessity of expressing these genes for reducing PQS concentration. Overexpression 
of PA5507 in the prematurely terminated qapR mutant (qapR-C90G) was sufficient to 
reduce PQS concentration by approximately 90% while expressing PA5508 or PA5509 
had no effect on PQS concentration (Fig. 3). A reporter fusion driven by the natural 
qapR promoter was then utilized to determine that translation of the enzyme encoded 
by PA5507 was significantly lower in the premature termination mutant (qapR-C90G) 
compared to the deletion mutant (∆qapR) (Fig. 4). This suggested that qapR and 
PA5507 were coupled at the translational level. 
To ensure that this result was not due to discrepancies in transcription, the 
reporter fusions were placed under the control of the constitutive lacUV5 promoter. 
These constructs also showed that PA5507 translation was significantly reduced when 
QapR translation is prematurely terminated early in the polypeptide (Fig. 5). 
Translational activity was mostly restored to PA5507 when the premature stop codon 
was moved downstream to within 60 nucleotides from the PA5507 start codon (∆qapR-
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G805T) (Fig. 5). This result confirmed that QapR and PA5507 translation is coupled. 
We have shown that mutation of the putative ribosome binding site upstream (RBS) 
from PA5507 in the qapR coding region greatly reduces translation of PA5507 (Fig. 6). 
However, this mutation does not completely abolish PA5507 translation (similar to 
premature termination of QapR) leading us to conclude that de novo initiation at the 
RBS of PA5507 is likely to drive most PA5507 expression but re-initiation from 
ribosomes terminated at the QapR stop codon cannot be ruled out. These findings were 
correlated to PQS concentration by showing that the ∆qapR-C651G and ∆qapR-RBS-
mut mutations had only a minimal effect on PQS concentration (Fig. 6). However, 
premature termination of QapR translation with the ∆qapR-G805T mutation greatly 
reduced PQS concentration (Fig. 6).  
To help understand what these data mean, a potential model of qapR operon 
regulation is presented in Figure 7. This model shows the QapR regulator repressing 
transcription of the qapR operon and this repression is required for P. aeruginosa to 
produce a high concentration of the signaling molecule PQS. The inset depicts the 
effects of QapR termination either proximal or distal to the PA5507 translational start 
codon. When QapR translation is terminated distal from PA5507, PQS concentration is 
protected due to low translation of PA5507 even if the qapR-PA5509 operon is 
overexpressed at the transcriptional level. This regulation scheme ensures that a high 
concentration of PQS will be present even if a lesion in the qapR coding region has 
been acquired since translation of the regulator is coupled to the downstream gene. The 
qapR operon is regulated at multiple levels in P. aeruginosa which may indicate its role 
in reducing quinolone production under a specific growth condition. 
 Fig. 3.7. Model of qapR operon regulation.
genes qapR, PA5507, PA5508
single polycistronic mRNA whose transcription is repressed by QapR. The inset box 
highlights the qapR-PA5507 intergenic region. We have implicated at least two factors 
that are required for qapR operon enzymes (PA5507, PA5508, and PA5509) to affect 
PQS concentration in P. aeruginosa
the PA5507 start codon (up to 60 bp away) allows for full translational activity while 
QapR termination distal to PA5507 
activity. Second, QapR is an auto
the qapR operon at a low level in PAO1. This repression is alleviated in the mutated 
strains. The combination of high 
then yields a low PQS phenotype.
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The qapR operon is encoded by all sequenced strains of P. aeruginosa listed on 
the Pseudomonas Genome Database [105]. Six other Pseudomonas species (P. 
brassicacearum, P. chlororaphis, P. fluroescens, P. protegens, P. mandelii, and P. 
knackmussi) were also found to encode the intact qapR operon. The majority of 
Pseudomonas strains encode homologs of qapR operon genes but the organization and 
location of the operon is not conserved. This information does not allow us to propose a 
function for the qapR operon other than its role in reducing PQS concentration in P. 
aeruginosa. This operon likely provides a catabolic pathway for a nutrient because 
homologous operons are also found outside of the Pseudomonas genus. The qapR 
operon structure is conserved in many sequenced members of the Proteobacteria 
phylum including several soil/rhizosphere α-Proteobacteria such as Ochrobactrum 
anthropic, Ensifer adhaerens, and Mesorhizobium spp. These organisms can be free-
living in the environment (soil or water) or associated with plants as pathogens or 
rhizosphere symbionts. Other Proteobacteria encode all genes of the operon but with 
scrambled organization including the α-proteobacteria Sinorhizobium meliloti and S. 
medicae, the β-proteobacterium Burkholderia oklahomensis, and the γ-proteobacterium 
Klebsiella pneumonia. This vast distribution among an entire phylum of bacteria 
indicates that the qapR operon is utilized in some way by all of these organisms 
whether in a pathogenic or free-living niche but does not allow for speculation of 
function.  
The organisms that retain the qapR operon genes in scrambled order are not 
likely to exhibit the same regulation scheme as P. aeruginosa. Transcriptional regulation 
may be similar due to the presence of an RpiR-type homolog in each organism but 
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translational coupling of this regulator to a functional enzyme as seen in P. aeruginosa 
is not likely to be conserved. In most cases of coupling, translation of an upstream open 
reading frame positively influences translation of a downstream open reading frame on 
the same polycistronic mRNA. In the plant pathogen Agrobacterium tumefaciens, virB7-
virB8 encode components of the secretion apparatus complex. These two genes 
overlap by 8 nucleotides and are translationally coupled to ensure proper formation of 
the T-pilus for injection of tumor-inducing DNA into host plant cells [68]. Coupling of 
virB7-virB8 is similar to qapR-PA5507 coupling but the qapR-PA5507 coding sequences 
do not overlap. In Salmonella typhimurium, the ompR-envZ two-component system is 
translationally coupled to ensure that a proper intracellular concentration of both 
proteins is produced for appropriate signal transduction [58]. Coupling of this two-
component system is similar to that of qapR-PA5507 in that a transcriptional regulator is 
coupled to a functional protein. However, ompR-envZ share an overlapping start/stop 
codon (ATGA) and envZ has no ribosome binding site for de novo translation initiation 
which is not similar to qapR-PA5507 coupling where a 4 bp intergenic region separates 
the genes and a strong RBS controls PA5507 translation. Conversely, open reading 
frames in polycistronic operons do not have to be translationally coupled as is the case 
with the pvuIIC-pvuIIR restriction-modification genes from Proteus vulgaris. These two 
genes overlap by 20 nucleotides but are not coupled at the translational level [43]. 
These slight differences contribute to the difficulty of predicting translational coupling 
which is likely an under-appreciated regulation mechanism in prokaryotes. 
In P. aeruginosa, translational coupling of qapR to PA5507 provides for multiple 
levels of regulation of an enzyme that can negatively affect PQS concentration. This 
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regulation is likely important not only for virulence in acute infections but also for biofilm 
formation in chronic infections, both of which require PQS signaling [20]. QapR 
represses transcription of the qapR operon to protect PQS production in vivo. This 
regulator should respond to an as-of-yet undiscovered molecule to alleviate 
transcriptional repression of the operon similar to homologous RpiR-type regulators 
[15]. The QapR ligand molecule could be produced or accumulate in response to a 
stressor in the environment and would cause the cells to reduce quinolone production, 
possibly due to quinolone pro-oxidant characteristics [32]. However, if a mutation was 
accumulated in qapR that prematurely terminates translation of the regulator then 
PA5507 would not be efficiently translated even though it would be transcribed at a high 
level. These systems appear to be in place to regulate the concentration of quinolone 
present at any given time during the course of growth (whether environmental or 
pathogenic) to contribute to the vast continuum of signals to which P. aeruginosa can 
sense and respond. 
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Table 3.1 Bacterial strains and plasmids used in this study. 
Strain or Plasmid Relevant genotype or 
phenotype 
Reference or source 
E. coli DH5α λ-φ80dlacZ∆M15 
∆(lacZYA-argF) U196 
recA1 endA1 hsdR17(rK- 
mK
-) supE44 thi-1 gyrA 
relA1 
[106]  
 
P. aeruginosa strains 
  
   PAO1 Wild-type [36] 
   PKT-QapR1 qapR deletion mutant 
derived from PAO1 
[98] 
   PKT-QapR-C90G Point mutant of qapR 
derived from PAO1  
This study 
   PKT-QapR1-RBS mut. qapR deletion mutant with 
PA5507 RBS mutation 
derived from PAO1 
This study 
   PKT-QapR1-C651G qapR deletion mutant with 
point mutation at 
nucleotide 651 derived 
from PAO1 
This study 
   PKT-QapR1-G805T qapR deletion mutant with 
point mutation at 
nucleotide 805 derived 
from PAO1 
This study 
      
Plasmids   
   pHERD20T E. coli/P. aeruginosa 
shuttle expression vector 
[85] 
   pSW205 Translational lacZ fusion 
vector 
[102] 
   pLP5506 qapR’-lacZ transcriptional 
fusion 
[98] 
   p∆qapR ∆qapR suicide vector on 
pEX18Ap 
[98] 
   pEX18Ap Suicide vector for P. 
aeruginosa 
[34] 
   pqapR-large frag. qapR (with flanking 
sequence) suicide vector 
on pEX18Ap 
This study 
   pqapR-C90G qapR point mutant suicide 
vector on pEX18Ap 
This study 
   p∆qapR-RBS-mut ∆qapR-RBS-mut mutant 
suicide vector on pEX18Ap 
This study 
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   p∆qapR-C651G ∆qapR-C651G mutant 
suicide vector on pEX18Ap 
This study 
   p∆qapR-G805T ∆qapR-G805T mutant 
suicide vector on pEX18Ap 
This study 
   P5507Exp PBAD-PA5507 on 
pHERD20T 
This study 
   P5508Exp PBAD-PA5508 on 
pHERD20T 
This study 
   P5509Exp PBAD-PA5509 on 
pHERD20T 
This study 
   pqapR-07’(C90G) qapR-07’(C90G)-lacZ 
translational fusion 
This study 
   p∆qapR-07’ ∆qapR-07’-lacZ 
translational fusion 
This study 
   pqapR’lacUV5 PlacUV5-qapR’-lacZ 
translational fusion 
This study 
   pqapR-07’lacUV5 PlacUV5-qapR-07’-lacZ 
translational fusion 
This study 
   pqapR-07’(C90G)lacUV5 PlacUV5-qapR-07’(C90G)-
lacZ translational fusion 
This study 
   pqapR-07’(C651G)lacUV5 PlacUV5-qapR-07’(C651G)-
lacZ translational fusion 
This study 
   pqapR-07’(G805T)lacUV5 PlacUV5-qapR-07’(G805T)-
lacZ translational fusion 
This study 
   pqapR-07’(RBS mut.)lacUV5 PlacUV5-qapR-07’(RBS 
mut.)-lacZ translational 
fusion 
This study 
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Table 3.2 Primers used in this study. 
Primer Sequence (5’→3’)a,b,c 
PA5507 expression 
 
   PA5507-09 Ex 1 AAAAACCATGGATGTTCAGCCTGCCCCACCA 
   5507 Ex 2.1 AAAAAAAGCTTACGAAGCTGACCAGGCGTACC 
  
PA5508 expression 
 
   5508 Ex 1 AAAAACCATGGGTGAACCGCCTGCAGCCGGT 
   5508 Ex 2 AAAAAAAGCTTCGGAATGTGCCGGCTGGCAT
G 
  
PA5509 expresssion 
 
   5509 Ex 1 AAAAACCATGGGTGGTCCTGGTCTGCGAGCA 
   PA5507-09 Ex 2 AAAAAAAGCTTACGGGCTCCTCGGGAAAAGG 
  
qapR-07’(C90G)/ 
∆qapR-07’ TL fusion 
 
   5506-lacZ1 TL AAAAAGAATTCCAAAGGCGCGGTGGTACCGG 
   5507-lacZ2.1 TL AAAAAGGATCCGCACGCTGCATGTCGACGA 
  
qapR’ lacUV5 TL fusion  
   5506-lacZTL-UV5Up AAAAAGAATTCAGGCTTTACACTTTATGCTTCC
GGCTCGTATAATGTGTGGACCTTCGAGGATGC
CCCATGCAAGAACTA 
   5506-lacZ2.1 TL AAAAAGGATCCACCACCTTGCGCTCCGCG 
  
qapR-07’ lacUV5/ 
qapR-07’(C90G) lacUV5 TL fusion 
 
   5506-lacZTL-UV5Up See above 
   5507-lacZTL-UV5Dn AAAAAGGATCCGCACGCTGCATGTCGACGAA
CAGG 
  
qapR-07’(C651G) lacUV5 TL 
fusion 
 
   5506-lacZTL-UV5Up See above 
   C651GInv. 2 CTAGATGTCGGTGAACAGCACCAGCCG 
     
   C651GInv. 1 GCCTCGCCGCTGCGCGAA 
   5507-lacZTL-UV5Dn See above 
qapR-07’(G805T) lacUV5 TL fusion  
   5506-lacZTL-UV5Up See above 
   G805TInv. 2 CAGGCGTTCGTCGAGCGGC 
  
   G805TInv. 1 TAGGGCATCGACCAGCTCCGCAAC 
   5507-lacZTL-UV5Dn See above 
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qapR-07’(RBS mut.) lacUV5 TL 
fusion 
 
   5506-lacZTL-UV5Up See above 
   5507-mut.RBS 2 CCAGAATATGACTGCTGAACGCGTTGCG 
  
   5507-mut.RBS 1 TTTTTTGACCCGATGTTCAGCCTGCCC 
   5507-lacZTL-UV5Dn See above 
  
qapR large frag.  
   5506 Up 1 AAAAAAAGCTTGCTGATCCTCGTCCAGATTC 
   5506 Down 2 AAAAAAAGCTTTGCTCTCGTCGATCAGGTC 
  
qapR-C90G  
   5506-C90GInv 1 GCCGCGCCTCGGCCTCG 
   5506-C90GInv 2 TAGTCATCGAGCAGGGCACGCAC 
  
∆qapR-RBS-mut  
   5506 Up 1 See above 
   5507-mut.RBS 2 See above 
  
   5507-mut.RBS 1 See above 
   5506 Down 2 See above 
  
∆qapR-C651G  
   5506 Up 1 See above 
   5506-90 rev GTAGTCATCGAGCAGGGCAC 
  
   C561Gforward.2 TAGGCCTCGCCGCTGCGC 
   5506 Down 2 See above 
  
∆qapR-G805T  
   5506 Up 1 See above 
   5506-90 rev See above 
  
   G805Tforward TAGGGCATCGACCAGCTC 
   5506 Down 2 See above 
aUnderlined sequence denotes restriction site utilized for cloning. 
bItalicized sequence denotes PlacUV5 promoter sequence. 
cBold sequence denotes bases that have been mutated for this study. 
  
 
CHAPTER FOUR: GENERAL SUMMARY 
 The goal of these studies was to investigate an operon that can modulate PQS 
concentration through an unknown mechanism in P. aeruginosa. Since PQS is an 
important molecule for virulence, mechanisms that abrogate or dysregulate PQS 
production could be utilized as targets for anti-infective drugs. The goal of studying 
these mechanisms is to find a means to reduce virulence without placing significant 
selective pressure on infecting organisms as traditional antibiotics do since they are 
directed at required physiological processes (i.e.- transcription/translation). We live in 
the age of antibiotic resistance and any tactic of reducing virulence of microorganisms 
should be investigated vigorously. 
 We initiated these studies with the knowledge that a mechanism of reducing the 
PQS produced by P. aeruginosa is encoded on its genome. D’Argenio et al. identified a 
transcriptional regulator (gene PA5506) that, when mutated, reverted autolytic colony 
morphology mutants back to the wild type PAO1 colony morphology [14]. The autolytic 
phenotype identified by D’Argenio was found to correlate with overproduction of PQS 
and autolysis suppressor mutants reduced the concentration of PQS. Insertion in 
PA5506 in the ∆pqsL background reduced PQS concentration to a level below that 
produced by the wild type strain PAO1.  
 An isogenic, in-frame deletion of gene PA5506 (renamed qapR) was constructed 
and this mutant was assessed for PQS and pyocyanin production. Fig. 2.1 shows that 
deletion of qapR reduces PQS and pyocyanin production significantly compared to the 
wild type strain PAO1. PQS and pyocyanin levels can be restored to the wild type level 
by providing qapR on a plasmid under the control of an inducible promoter 
 85 
 
(Fig. 2.1). This effect is due to QapR binding the qapR promoter which represses 
transcription of the qapR operon and leads to reduced expression of the enzymes of the 
qapR operon.  We could not immediately infer a role for qapR, which is homologous to 
regulators of carbohydrate metabolism genes, in controlling PQS concentration so we 
investigated transcription of the PQS biosynthetic operon. We found that transcription 
from a pqsA’-lacZ reporter fusion was significantly decreased in the ∆qapR mutant 
compared to strain PAO1 (Fig. 2.2A). This was expected due to the reduced PQS 
concentration produced by the ∆qapR mutant since PqsR requires PQS to positively 
regulate transcription of pqsA (the first gene of the PQS biosynthetic operon). Addition 
of exogeneous PQS to cultures restored pqsA’-lacZ activity in the ∆qapR mutant to 
nearly a wild type level which suggested that PqsR was present to bind PQS and 
activate transcription of the PQS biosynthetic operon (Fig. 2.2A). Transcription from the 
pqsR promoter was found to be unaffected by mutation of qapR further confirming that 
PqsR is present and functional in the ∆qapR mutant (Fig. 2.2B). We also found that 
addition of the precursor anthranilate could not restore PQS production to the ∆qapR 
mutant (Fig. 4.1) but overexpression of PqsABCD could restore PQS and pyocyanin 
production to the ∆qapR mutant (Fig. 2.2C & D). These results led us to conclude that 
precursor pools for quinolone production are unaffected by qapR mutation. The 
regulatory gene qapR was predicted to lead an operon of four genes and we assessed 
transcript structure with reverse transcriptase-PCR. Fig. 2.3 shows that qapR is co-
transcribed with the three downstream genes PA5507, PA5508, and PA5509. This lead 
us to investigate the regulation of this operon by constructing a qapR’-lacZ reporter  
 
 
  
Figure 4.1. Anthranilic acid supplementation cannot restore PQS concentration in 
the ∆qapR mutant. Strains are noted below each bar, PAO1 is the wild type strain and 
∆qapR is the qapR deletion mutant. Cultures were grown for 18h in LB medium
supplemented with dH2O or 0.5 mM anthranilic acid in dH
with acidified ethyl acetate and PQS was quantified via TLC and densitometry 
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2O. Cultures were extracted 
 
 
[8, 14]. 
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fusion. We found that transcription of the qapR operon was increased in the ∆qapR 
mutant compared to wild type strain PAO1 (Fig. 2.4A). We confirmed this derepression 
of transcription by utilizing quantitative real-time PCR and found that genes PA5507, 
PA5508, and PA5509  are transcribed more than 15-fold higher in the ∆qapR mutant 
compared to wild type strain PAO1 (Fig. 2.4B). We found that QapR is an 
autoregulatory transcription factor through electrophoretic mobility shift assays with 
radiolabeled qapR promoter. Fig. 2.5A shows that QapR-containing lysate could interact 
with the qapR promoter region independently of any added ligand. QapR was unable to 
interact with a control promoter (pqsA) under the same binding conditions as those used 
for the qapR promoter which indicates that the binding is specific to a sequence within 
the qapR promoter (Fig. 2.5B). This led us to assess the effect of overexpression of the 
functional genes of the qapR operon. We constructed an expression vector containing 
PA5507-PA5508-PA5509 under the control of an inducible promoter and expression of 
these three genes was sufficient to significantly reduce PQS concentration in the wild 
type strain PAO1 (Fig. 2.6). We then constructed mutants of qapR operon enzyme 
genes individually and in combination with the qapR regulator. Fig. 2.7 shows that 
deletion of any of the qapR operon enzymes (PA5507, PA5508, or PA5509) in 
combination with qapR can restore high PQS concentration to the ∆qapR mutant, 
similar to the wild type strain PAO1. This result confirms that the qapR operon is 
responsible for reducing PQS concentration in the ∆qapR mutant. 
  Further investigation of two different qapR transposon mutants led us to suspect 
that a post-transcriptional regulatory element existed in the qapR coding region. In 
these mutants, the qapR coding sequence was interrupted but differential PQS 
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phenotypes were obtained (Fig 4.2). The transposon mutant from D’Argenio yielded 
greatly reduced PQS concentration while the qapR transposon from the PA14 Non-
Redundant library produced a concentration of PQS similar to the wild type strain.  We 
set out to investigate this by constructing a P. aeruginosa strain that carried a point 
mutation which introduced a premature stop codon in qapR. This mutation prevented 
QapR translation while preserving the remaining qapR coding sequence. This mutant, 
qapR-C90G, displayed increased transcription of the qapR operon as expected from a 
qapR mutant (Fig. 3.1). Surprisingly, this mutant did not exhibit reduced PQS 
concentration as would be expected from a qapR mutant (Fig. 3.2). This result 
suggested that one of the qapR operon enzymes may not be efficiently translated since 
elevated transcription of the qapR operon would normally give correspondingly higher 
protein expression and subsequently low PQS concentrations. We constructed 
expression vectors for the enzymes of the qapR operon, individually. Fig. 3.3 shows that 
expression of only PA5507 in the qapR-C90G point mutant is required to reduce PQS 
concentration. This result suggests that the other enzymes of the operon (PA5508 and 
PA5509) are present at a sufficient level for the pathway to reduce PQS concentration 
when PA5507 is provided in trans. In order to investigate the requirements for PA5507 
translation, we constructed lacZ reporter fusions that contained either the ∆qapR mutant 
allele or the qapR-C90G mutant allele with PA5507 fused to lacZ. Fig. 3.4 shows that 
PA5507 translation is significantly reduced when comparing the activity of the deletion 
mutant construct to the activity of the point mutant. We then located the transcriptional 
start site for the qapR operon in order to construct lacZ fusions that are transcriptionally 
driven by a foreign promoter. In these fusion constructs, the lacUV5 promoter drives  
 Figure 4.2. L64R2 and PA14 transposon mutant PQS visualized via thin layer 
chromatography. PQS was extracted from 
plates, and visualized under UV light. (Left panel) Transposon mutants in 
PA5506, pqsL show PQS overproduction in the 
introduction of a lesion into the 
Transposon mutant in the PA14 strain shows that insertion in 
PQS concentration. 
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P. aeruginosa cultures, separated on TLC 
pqsL mutant which is reduced upon 
PA5506 coding sequence [14]. (Right panel) 
PA5506 has no effect on 
 
 
 
pqsL and 
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transcription of qapR carrying the wild type allele or one of the following point mutant 
alleles: qapR-C90G, qapR-C651G, or qapR-G805T with PA5507 fused to lacZ. These 
fusions were designed to investigate the effect of QapR translation on translation of 
PA5507. Fig. 3.5 shows that termination of QapR translation distal to the start codon of 
PA5507 has a negative effect on translational activity. This effect is negated when 
QapR translation is terminated proximal (within 60 bp) to the PA5507 start codon. Since 
translation of PA5507 is dependent upon translation of the upstream gene qapR, we 
concluded that QapR and PA5507 are translationally coupled. We then investigated the 
putative ribosome binding site (RBS) located upstream from PA5507 within the qapR 
coding sequence. When this RBS was mutated, PA5507 translation was dramatically 
decreased based on lacZ reporter fusion activity (Fig. 3.6B). This led us to conclude that 
the RBS upstream from PA5507 is functional for initiating translation but may be 
occluded when QapR translation is prematurely terminated. We then sought to correlate 
the effects of these mutations on PA5507 translation as it relates to PQS concentration. 
Fig. 3.6D shows that premature termination of QapR translation further than 60 
nucleotides upstream from the PA5507 start codon or mutation of the PA5507 RBS 
does not significantly affect PQS concentration. Based on these findings, we concluded 
that PQS concentration is inversely correlated to PA5507 translation. We can also 
suggest that these regulatory mechanisms are in place to prevent PA5507 from 
dampening PQS-mediated signaling in P. aeruginosa. If expression of PA5507 was not 
tightly controlled, P. aeruginosa would not be able to produce sufficient concentrations 
of PQS for proper signaling. This regulation may also comprise a mechanism to prevent 
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P. aeruginosa from overproducing PQS to the detriment of the cell since derepression 
of the qapR operon can effectively reduce PQS concentration in vivo. 
 In this regulatory network, QapR represses transcription of the qapR operon and 
likely allows for a basal level of expression of the enzymes of the operon. We speculate 
that transcriptional repression would only be alleviated after the unknown cofactor of 
QapR reached a sufficient concentration within the cell for QapR to bind it and cause its 
release from the qapR promoter. As long as the QapR cofactor was at a high 
concentration, transcription of the qapR operon would proceed uninhibited and would 
lead to elevated transcription of the qapR operon. If translation of QapR has not been 
prematurely interrupted by mutation, then PA5507 will be translated efficiently and will 
be expressed at a level sufficient to reduce PQS concentration with the enzymatic 
actions of PA5508 and PA5509. However, if QapR has incurred a mutation that would 
negatively affect translation, then PA5507 would not be translated efficiently and PQS 
concentration would be unaffected. Likewise, if the QapR cofactor concentration 
decreases then transcription would be repressed by QapR without the cofactor. This 
suggests that the qapR operon is intricately regulated by transcriptional repression and 
translational coupling to the regulatory protein that controls transcription of the operon.  
 There are several interesting facets of this operon and its regulation that have yet 
to be explored. In the future, identifying the QapR co-factor is a very important goal. It 
has been shown that members of the RpiR-family of transcriptional regulators bind 
intermediates of pathways they regulate to alter transcription of target genes [15]. If the 
co-factor is a soluble, non-toxic compound, then fighting P. aeruginosa virulence from 
within by reducing PQS concentration through the action of the qapR operon may be 
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possible. Defining the QapR regulon is also a worthwhile study that should establish the 
gene/s regulated directly by QapR. It is possible that QapR serves only to regulate the 
qapR operon, but this seems unlikely considering the integration of regulatory networks 
within P. aeruginosa.  
The main challenge for future studies of the qapR operon will be to define the 
mechanism by which the operon enzymes reduce PQS concentration in P.  
aeruginosa. The PA5507 enzyme has sequence homology to isochorismatases which 
are predicted to catalyze the breakdown of isochorismate to pyruvate and (2S,3S)-2,3-
dihydroxy-2,3-dihydrobenzoate. PA5508 has sequence homology to glutamine 
synthetases and Ladner et al. demonstrated that the enzyme exhibits γ-glutamyl 
monoamine ligase activity in vitro [51]. PA5509 has sequence homology to 
amidohydrolases which are predicted to catalyze the conversion of N-formyl-L-
glutamate to formate and L-glutamate. The homologies of PA5507 and PA5509 and the 
established activity of PA5508 in vitro do not yield an obvious pathway that would 
involve quinolones directly. However, there are a few possible routes through which the 
qapR operon enzymes could be affecting PQS concentration in P. aeruginosa. The 
qapR operon could be altering PQS directly by addition or subtraction of a functional 
group (i.e.- amine group or acyl chain) which would reduce the bioactivity of the PQS 
molecule. This alteration could prevent PqsR from binding altered PQS and block the 
positive effect that PqsR-PQS exerts on the pqsABCDE operon (see Fig. 4.3A for a 
potential model). Another possible mechanism for the qapR operon to reduce PQS 
concentration would be through alteration of a precursor molecule required for  
 
 
 Figure 4.3. Schematic representation of putative 
(A) Direct modification of PQS by the 
bioactivity by preventing proper binding of the signal by the regulator PqsR. (B) Malonyl
CoA is a precursor of PQS biosynthesis and modification of this molecule could prevent 
PQS biosynthesis by perturbing the malonyl
converted to an unknown metabolite by the 
could inhibit the activity of one of the
example).  
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qapR operon enzyme function. 
qapR operon enzymes would reduce PQS 
-CoA pool. (C) A molecule may be 
qapR operon enzymes. This metabolite 
 PQS biosynthetic enzymes (PqsA is shown as an 
 
 
 
-
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quinolone biosynthesis. This action would prevent the quinolone biosynthetic machinery 
from producing PQS due to deficient precursor pools (Fig. 4.3B). We speculated that 
anthranilate was the precursor affected by the qapR operon but supplementing cultures 
with anthranilate did not restore PQS concentration to the ∆qapR mutant (Fig. 4.1). 
Quinolone biosynthesis requires the precursors anthraniloyl-CoA, malonyl-CoA, and 
octanoyl-CoA so perhaps one of the other precursors is affected by the qapR operon. 
Finally, the qapR operon could be producing a metabolite that has a negative effect on 
PQS production in P. aeruginosa. This metabolite would likely be structurally similar to a 
quinolone precursor molecule that could inhibit an enzyme required for PQS production 
(Fig. 4.3C). Coleman et al. showed that analogs of anthranilate could reduce PQS 
production by inhibiting the activity of PqsA in vitro and in vivo [12]. One molecule found 
to inhibit PqsA activity was salicylate which is similar to (2S,3S)-2,3-dihydroxy-2,3-
dihydrobenzoate molecule which is a product of the putative isochorismate reaction. 
The discovery of the true reaction mechanism catalyzed by the qapR operon could one 
day open new avenues of research and allow for the development of anti-infective 
compounds aimed at reducing P. aeruginosa virulence.  
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